U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Forman-Hoffman V, Middleton JC, Feltner C, et al. Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May. (Comparative Effectiveness Review, No. 207.)

Cover of Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update

Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder: A Systematic Review Update [Internet].

Show details

Appendix DExcluded Studies

X1.

Not original research

X2.

Ineligible study design

X3.

Ineligible population

X4.

Ineligible intervention

X5.

Ineligible comparator

X6.

Ineligible outcome

X7.

Ineligible study duration

X8.

Ineligible setting

X9.

Ineligible sample size

X10.

Not in English

X11.

Irretrievable

X12.

Retracted

1.
Psychotherapies for panic disorder: A tale of two sites. Journal of Clinical Psychiatry. 77 (7) (pp 927–935), 2016. Date of Publication: July 2016.; 2016. Exclusion Code: X3. [PubMed: 27464313]
2.
Acierno RE, Gros DF, Ruggiero KJ, et al Behavioral activation and therapeutic exposure for posttraumatic stress disorder: a noninferiority trial of treatment delivered in person versus home-based telehealth. Depress Anxiety. 2016-12-01;33(5):415–23. doi: http://dx​.doi.org/10.1002/da.22476. PMID: 1844925103; 45795. Exclusion Code: X5. [PubMed: 26864655]
3.
Acierno RE, Knapp RG, Tuerk PW, et al A non-inferiority trial of prolonged exposure for posttraumatic stress disorder: in person versus home-based telehealth. Behav Res Ther. 2016-12-29;89:57–65. doi: http://dx​.doi.org/10​.1016/j.brat.2016.11.009. PMID: 1853730980; 45948. Exclusion Code: X5. [PMC free article: PMC5222772] [PubMed: 27894058]
4.
Aderka IM, Gillihan SJ, McLean CP, et al The relationship between posttraumatic and depressive symptoms during prolonged exposure with and without cognitive restructuring for the treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2013 Jun;81(3):375–82. doi: 10.1037/a0031523. PMID: 23339538. Exclusion Code: X5. [PubMed: 23339538] [CrossRef]
5.
Ahearn EP, Krohn A, Connor KM, et al Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use. Ann Clin Psychiatry. 2016-09-15;15(3/4):193–201. doi: http://dx​.doi.org/10​.1023/B:ACLI.0000008173.01153.4e. PMID: 42422469; 26213. Exclusion Code: X2. [PubMed: 14971865]
6.
Ahmadi K, Hazrati M, Ahmadizadeh M, et al REM desensitization as a new therapeutic method for post-traumatic stress disorder: a randomized controlled trial. Acta Med Indones. 2015 Apr;47(2):111–9. PMID: 26260553. Exclusion Code: X3. [PubMed: 26260553]
7.
Ahmadi N, Moss L, Simon E, et al Efficacy and long-term clinical outcome of comorbid posttraumatic stress disorder and major depressive disorder after electroconvulsive therapy. Depress Anxiety. 2017-01-16;33(7):640–7. doi: http://dx​.doi.org/10.1002/da.22451. PMID: 1758136749; 44580. Exclusion Code: X4. [PubMed: 26555786]
8.
Ahmadpanah M, Sabzeiee P, Hosseini SM, et al Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology. 2014;69(4):235–42. doi: 10.1159/000362243. PMID: 24993832. Exclusion Code: X5. [PubMed: 24993832] [CrossRef]
9.
Albert U, Carmassi C, Cosci F, et al Role and clinical implications of atypical antipsychotics in anxiety disorders, obsessive-compulsive disorder, trauma-related, and somatic symptom disorders: A systematized review. Int Clin Psychopharmacol. 2016;31(5):249–58. doi: 10.1097/YIC.0000000000000127. PMID: 2016-40188-002. Exclusion Code: X2. [PubMed: 26974213] [CrossRef]
10.
Aldahadha B, Al-Harthy H, Sulaiman S. The Efficacy of Eye Movement Desensitization Reprocessing in Resolving the Trauma Caused by the Road Accidents in the Sultanate of Oman. Journal of Instructional Psychology. 2012;39(3/4):146–58. PMID: 107974814. Language: English. Entry Date: 20131007. Revision Date: 20150712. Publication Type: Journal Article. Exclusion Code: X3.
11.
Alghamdi M, Hunt N, Thomas S. The effectiveness of Narrative Exposure Therapy with traumatised firefighters in Saudi Arabia: a randomized controlled study. Behav Res Ther. 2015 Mar;66:64–71. doi: 10.1016/j.brat.2015.01.008. PMID: 25701801. Exclusion Code: X3. [PubMed: 25701801] [CrossRef]
12.
Allan NP, Short NA, Albanese BJ, et al Direct and Mediating Effects of an Anxiety Sensitivity Intervention on Posttraumatic Stress Disorder Symptoms in Trauma-Exposed Individuals. Cogn Behav Ther. 2015;44(6):512–24. doi: 10.1080/16506073.2015.1075227. PMID: 26427912. Exclusion Code: X6. [PubMed: 26427912] [CrossRef]
13.
Allen AR, Newby JM, Smith JC, et al Internet-based cognitive behavioural therapy (iCBT) for posttraumatic stress disorder versus waitlist control: study protocol for a randomised controlled trial. Trials. 2016-09-28;16(1) doi: http://dx​.doi.org/10​.1186/s13063-015-1059-5. PMID: 1823905154; 45339. Exclusion Code: X6. [PMC free article: PMC4666048] [PubMed: 26628268]
14.
Amos T, Stein DJ, Ipser JC. Pharmacological interventions for preventing post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2014 Jul 08(7):Cd006239. doi: 10.1002/14651858.CD006239.pub2. PMID: 25001071. Exclusion Code: X3. [PubMed: 25001071] [CrossRef]
15.
Andersen TE, Lahav Y, Ellegaard H, et al A randomized controlled trial of brief somatic experiencing for chronic low back pain and comorbid post-traumatic stress disorder symptoms. European Journal of Psychotraumatology. 2017 2017-07-06;8(1) doi: http://dx​.doi.org/10​.1080/20008198.2017.1331108. PMID: 1916303335; 48054. Exclusion Code: X3. [PMC free article: PMC5489867] [PubMed: 28680540]
16.
Anderson ML, Najavits LM. Does seeking safety reduce PTSD symptoms in women receiving physical disability compensation? Rehabil Psychol. 2014 Aug;59(3):349–53. doi: 10.1037/a0036869. PMID: 24978844. Exclusion Code: X3. [PubMed: 24978844] [CrossRef]
17.
Arnone R, Orrico A, D’Aquino G, et al [EMDR and psychopharmacological therapy in the treatment of the post-traumatic stress disorder]. Rivista di psichiatria; 2012. p. 8–11. Exclusion Code: X10. [PubMed: 22622278]
18.
Baas MAM, Stramrood CAI, Dijksman LM, et al The OptiMUM-study: EMDR therapy in pregnant women with posttraumatic stress disorder after previous childbirth and pregnant women with fear of childbirth: design of a multicentre randomized controlled trial. European Journal of Psychotraumatology. 2017-03-30;8(1) doi: http://dx​.doi.org/10​.1080/20008198.2017.1293315. PMID: 1882073329; 47084. Exclusion Code: X6. [PMC free article: PMC5345578] [PubMed: 28348720]
19.
Baker DG, Diamond BI, Gillette G, et al A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995 Dec;122(4):386–9. PMID: 8657838. Exclusion Code: X4. [PubMed: 8657838]
20.
Baniasadi M, Hosseini G, Fayyazi Bordbar MR, et al Effect of pregabalin augmentation in treatment of patients with combat-related chronic posttraumatic stress disorder: a randomized controlled trial. J Psychiatr Pract. 2014 Nov;20(6):419–27. doi: 10.1097/01.pra.0000456590.12998.41. PMID: 25406046. Exclusion Code: X4. [PubMed: 25406046] [CrossRef]
21.
Barrera TL, Mott JM, Hofstein RF, et al A meta-analytic review of exposure in group cognitive behavioral therapy for posttraumatic stress disorder. Clin Psychol Rev. 2016-09-15;33(1):24–32. doi: http://dx​.doi.org/10​.1016/j.cpr.2012.09.005. PMID: 1284061343; 39700. Exclusion Code: X2. [PubMed: 23123568]
22.
Bass JK, Annan J, McIvor Murray S, et al Controlled trial of psychotherapy for Congolese survivors of sexual violence. N Engl J Med. 2013 Jun 06;368(23):2182–91. doi: 10.1056/NEJMoa1211853. PMID: 23738545. Exclusion Code: X3. [PubMed: 23738545] [CrossRef]
23.
Belsher BE, Jaycox LH, Freed MC, et al Mental health utilization patterns during a stepped, collaborative care effectiveness trial for PTSD and depression in the military health system. Med Care. 2016-09-15;54(7) doi: http://dx​.doi.org/10​.1097/MLR.0000000000000545. PMID: 1812432301; 45093. Exclusion Code: X4. [PubMed: 27111751]
24.
Bergen-Cico D, Possemato K, Pigeon W. Reductions in cortisol associated with primary care brief mindfulness program for veterans with PTSD. Med Care. 2014 Dec;52(12 Suppl 5):S25–31. doi: 10.1097/mlr.0000000000000224. PMID: 25397819. Exclusion Code: X4. [PubMed: 25397819] [CrossRef]
25.
Berger R, Abu-Raiya H, Benatov J. Reducing primary and secondary traumatic stress symptoms among educators by training them to deliver a resiliency program (ERASE-Stress) following the Christchurch earthquake in New Zealand. Am J Orthopsychiatry. 2016 Mar;86(2):236–51. doi: 10.1037/ort0000153. PMID: 26963188. Exclusion Code: X3. [PubMed: 26963188] [CrossRef]
26.
Berger W, Mendlowicz MV, Marques-Portella C, et al Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(2):169–80. doi: 10.1016/j.pnpbp.2008.12.004. PMID: 2009-02892-001. Exclusion Code: X2. [PMC free article: PMC2720612] [PubMed: 19141307] [CrossRef]
27.
Bisson JI, Roberts NP, Andrew M, et al Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults. Cochrane Database Syst Rev. 2013 Dec 13(12):Cd003388. doi: 10.1002/14651858.CD003388.pub4. PMID: 24338345. Exclusion Code: X2. [PMC free article: PMC6991463] [PubMed: 24338345] [CrossRef]
28.
Bolton P, Bass JK, Zangana GA, et al A randomized controlled trial of mental health interventions for survivors of systematic violence in Kurdistan, Northern Iraq. BMC Psychiatry. 2014 Dec 31;14:360. doi: 10.1186/s12888-014-0360-2. PMID: 25551436. Exclusion Code: X3. [PMC free article: PMC4301059] [PubMed: 25551436] [CrossRef]
29.
Bolton P, Lee C, Haroz EE, et al A transdiagnostic community-based mental health treatment for comorbid disorders: development and outcomes of a randomized controlled trial among Burmese refugees in Thailand. PLoS Med. 2014 Nov;11(11):e1001757. doi: 10.1371/journal.pmed.1001757. PMID: 25386945. Exclusion Code: X3. [PMC free article: PMC4227644] [PubMed: 25386945] [CrossRef]
30.
Bomyea J, Stein MB, Lang AJ. Interference control training for PTSD: A randomized controlled trial of a novel computer-based intervention. J Anxiety Disord. 2015 Aug;34:33–42. doi: 10.1016/j.janxdis.2015.05.010. PMID: 26114901. Exclusion Code: X4. [PMC free article: PMC4532583] [PubMed: 26114901] [CrossRef]
31.
Bomyea JA. Evaluating the effect of a novel cognitive training program on PTSD symptoms [dissertation]; 2014. Exclusion Code: X5.
32.
Bormann JE, Oman D, Walter KH, et al Mindful attention increases and mediates psychological outcomes following mantram repetition practice in veterans with posttraumatic stress disorder. Med Care. 2014 Dec;52(12 Suppl 5):S13–8. doi: 10.1097/mlr.0000000000000200. PMID: 25397817. Exclusion Code: X4. [PubMed: 25397817] [CrossRef]
33.
Bountress KE, Badour C, Flanagan J, et al Treatment of co-occurring posttraumatic stress disorder and substance use: does order of onset influence outcomes? Psychological Trauma: Theory, Research, Practice, and Policy. 2017 2017-09-05 doi: http://dx​.doi.org/10.1037/tra0000309. PMID: 1935255290; 48754. Exclusion Code: X5. [PMC free article: PMC5797521] [PubMed: 28771018]
34.
Brief DJ, Rubin A, Keane TM, et al Web intervention for OEF/OIF veterans with problem drinking and PTSD symptoms: a randomized clinical trial. J Consult Clin Psychol. 2013 Oct;81(5):890–900. doi: 10.1037/a0033697. PMID: 23875821. Exclusion Code: X4. [PMC free article: PMC9169869] [PubMed: 23875821] [CrossRef]
35.
Brief DJ, Solhan M, Rybin D, et al Web-based alcohol intervention for veterans: PTSD, combat exposure, and alcohol outcomes. Psychological Trauma: Theory, Research, Practice, and Policy. 2017 2017-07-06 doi: http://dx​.doi.org/10.1037/tra0000281. PMID: 1916308764; 48173. Exclusion Code: X4. [PMC free article: PMC5711610] [PubMed: 28569525]
36.
Brom D, Stokar Y, Lawi C, et al Somatic experiencing for posttraumatic stress disorder: a randomized controlled outcome study. J Trauma Stress. 2017 2017-07-06;30(3):304–12. doi: http://dx​.doi.org/10.1002/jts.22189. PMID: 1916308516; 48274. Exclusion Code: X4. [PMC free article: PMC5518443] [PubMed: 28585761]
37.
Brown AJ, Bollini AM, Craighead LW, et al Self-monitoring of reexperiencing symptoms: a randomized trial. J Trauma Stress. 2014 Oct;27(5):519–25. doi: 10.1002/jts.21950. PMID: 25322881. Exclusion Code: X4. [PubMed: 25322881] [CrossRef]
38.
Bryant RA, Mastrodomenico J, Hopwood S, et al Augmenting cognitive behaviour therapy for post-traumatic stress disorder with emotion tolerance training: a randomized controlled trial. Psychol Med. 2013 Oct;43(10):2153–60. doi: 10.1017/s0033291713000068. PMID: 23406821. Exclusion Code: X5. [PubMed: 23406821] [CrossRef]
39.
Buhmann CB, Nordentoft M, Ekstroem M, et al The effect of flexible cognitive–behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: Pragmatic randomised controlled clinical trial. The British Journal of Psychiatry. 2016;208(3):252–9. doi: 10.1192/bjp.bp.114.150961. PMID: 2016-45907-010. Exclusion Code: X3. [PubMed: 26541687] [CrossRef]
40.
Cadth. Virtual reality exposure therapy for adults with post-traumatic stress disorder: a review of the clinical effectiveness (Structured abstract). Health Technology Assessment Database: Canadian Agency for Drugs and Technologies in Health (CADTH); 2014. Exclusion Code: X2. [PubMed: 25411679]
41.
Campbell L, Kenardy J, Andersen T, et al Trauma-focused cognitive behaviour therapy and exercise for chronic whiplash: protocol of a randomised, controlled trial. J Physiother. 2015 Oct;61(4):218. doi: 10.1016/j.jphys.2015.07.003. PMID: 26319283. Exclusion Code: X6. [PubMed: 26319283] [CrossRef]
42.
Carrico AW, Nation A, Gomez W, et al Pilot trial of an expressive writing intervention with HIV-positive methamphetamine-using men who have sex with men. Psychol Addict Behav. 2015 Jun;29(2):277–82. doi: 10.1037/adb0000031. PMID: 25437153. Exclusion Code: X3. [PMC free article: PMC5482007] [PubMed: 25437153] [CrossRef]
43.
Carter JJ, Gerbarg PL, Brown RP, et al Multi-component yoga breath program for Vietnam veteran post traumatic stress disorder: randomized controlled trial. Journal of Traumatic Stress Disorders and Treatment. 2017-03-30;2(3) doi: http://dx​.doi.org/10​.4172/2324−8947.1000108. PMID: 1882073114; 46976. Exclusion Code: X4.
44.
45.
Chen YR, Hung KW, Tsai JC, et al Efficacy of eye-movement desensitization and reprocessing for patients with posttraumatic-stress disorder: a meta-analysis of randomized controlled trials. PLoS One. 2014;9(8):e103676. doi: 10.1371/journal.pone.0103676. PMID: 25101684. Exclusion Code: X2. [PMC free article: PMC4125321] [PubMed: 25101684] [CrossRef]
46.
Chhatre S, Metzger DS, Frank I, et al Effects of behavioral stress reduction Transcendental Meditation intervention in persons with HIV. AIDS Care. 2013;25(10):1291–7. doi: 10.1080/09540121.2013.764396. PMID: 23394825. Exclusion Code: X3. [PMC free article: PMC3659206] [PubMed: 23394825] [CrossRef]
47.
Church D, Palmer-Hoffman J. TBI symptoms improve after PTSD remediation with emotional freedom techniques. Traumatology. 2014;20(3):172–81. doi: 10.1037/h0099831. PMID: 2014-20843-001. Exclusion Code: X6. [CrossRef]
48.
Church D, Sparks T, Clond M. EFT (Emotional Freedom Techniques) and Resiliency in Veterans at Risk for PTSD: a Randomized Controlled Trial. Explore: the journal of science and healing; 2017. p. 355–65. Exclusion Code: X3. [PubMed: 27543343]
49.
Church D, Yount G, Rachlin K, et al Epigenetic effects of PTSD remediation in veterans using clinical emotional freedom techniques: a randomized controlled pilot study. Am J Health Promot. 2017-03-01 doi: http://dx​.doi.org/10​.1177/0890117116661154. PMID: 1872797734; 46699. Exclusion Code: X3. [PubMed: 27520015]
50.
Cloitre M, Henn-Haase C, Herman JL, et al A multi-site single-blind clinical study to compare the effects of STAIR Narrative Therapy to treatment as usual among women with PTSD in public sector mental health settings: study protocol for a randomized controlled trial. Trials. 2014 May 29;15:197. doi: 10.1186/1745-6215-15-197. PMID: 24886235. Exclusion Code: X6. [PMC free article: PMC4071147] [PubMed: 24886235] [CrossRef]
51.
Cohen LR, Field C, Campbell AN, et al Intimate partner violence outcomes in women with PTSD and substance use: a secondary analysis of NIDA Clinical Trials Network “Women and Trauma” Multi-site Study. Addict Behav. 2013 Jul;38(7):2325–32. doi: 10.1016/j.addbeh.2013.03.006. PMID: 23584194. Exclusion Code: X5. [PMC free article: PMC3733335] [PubMed: 23584194] [CrossRef]
52.
Connolly SM, Roe-Sepowitz D, Sakai C, et al Utilizing community resources to treat PTSD: a randomized controlled study using thought field therapy. African Journal of Traumatic Stress. 2016-09-15;3(1):24–32. PMID: 1448203598; 87747. Exclusion Code: X4.
53.
Cook JM, Thompson R, Harb GC, et al Cognitive-behavioral treatment for posttraumatic nightmares: an investigation of predictors of dropout and outcome. Psychological Trauma: Theory, Research, Practice, and Policy. 2016-09-15;5(6):545–53. doi: http://dx​.doi.org/10.1037/a0030724. PMID: 1322711075; 40047. Exclusion Code: X5.
54.
Cooper AA, Zoellner LA, Roy-Byrne P, et al Do changes in trauma-related beliefs predict PTSD symptom improvement in prolonged exposure and sertraline? J Consult Clin Psychol. 2017;85(9):873–82. doi: 10.1037/ccp0000220. PMID: 2017-21374-001. Exclusion Code: X5. [PMC free article: PMC5578884] [PubMed: 28504542] [CrossRef]
55.
Cowlishaw S, Evans L, Suomi A, et al Couple and family therapies for post-traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews: John Wiley < Sons, Ltd; 2014. Exclusion Code: X6.
56.
Creech SK, Macdonald A, Benzer JK, et al PTSD symptoms predict outcome in trauma-informed treatment of intimate partner aggression. J Consult Clin Psychol. 2017 2017-09-05 doi: http://dx​.doi.org/10.1037/ccp0000228. PMID: 1935254515; 48678. Exclusion Code: X4. [PubMed: 28726440]
57.
Cusack KJ, Jonas DE, Forneris CA, et al Psychological treatments for adults with posttraumatic stress disorder: a systematic review and meta-analysis. Clin Psychol Rev. 2016-12-01;43:128–41. doi: http://dx​.doi.org/10​.1016/j.cpr.2015.10.003. PMID: 1844925267; 45735. Exclusion Code: X2. [PubMed: 26574151]
58.
David D, De Faria L, Lapeyra O, et al Adjunctive risperidone treatment in combat veterans with chronic PTSD. J Clin Psychopharmacol. 2004;24(5):556–8. doi: 10.1097/01.jcp.0000138771.46353.59. PMID: 2004-18897-017. Exclusion Code: X2. [PubMed: 15349018] [CrossRef]
59.
David D, De Faria L, Mellman TA. Adjunctive risperidone treatment and sleep symptoms in combat veterans with chronic PTSD. Depress Anxiety. 2006;23(8):489–91. doi: 10.1002/da.20187. PMID: 16845653. Exclusion Code: X2. [PubMed: 16845653] [CrossRef]
60.
Davidson J, Baldwin DS, Stein DJ, et al Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale. Int Clin Psychopharmacol. 2008 Sep;23(5):299–303. doi: 10.1097/YIC.0b013e32830c202d. PMID: 18703940. Exclusion Code: X1. [PubMed: 18703940] [CrossRef]
61.
Davidson J, Stein D, Rothbaum B, et al Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo. Journal of psychopharmacology (Oxford, England); 2012. p. 778–83. Exclusion Code: X2. [PubMed: 21926426]
62.
Davis LL, Frazier EC, Williford RB, et al Long-term pharmacotherapy for post-traumatic stress disorder. CNS Drugs. 2016-09-15;20(6):465–76. doi: http://dx​.doi.org/10​.2165/00023210-200620060-00003. PMID: 1081858172; 39304. Exclusion Code: X2. [PubMed: 16734498]
63.
Davis LL, Nugent AL, Murray J, et al Nefazodone treatment for chronic posttraumatic stress disorder: an open trial. J Clin Psychopharmacol. 2000 Apr;20(2):159–64. PMID: 10770453. Exclusion Code: X2. [PubMed: 10770453]
64.
Dawson KS, Schafer A, Anjuri D, et al Feasibility trial of a scalable psychological intervention for women affected by urban adversity and gender-based violence in Nairobi. BMC Psychiatry. 2016 Nov 18;16(1):410. doi: 10.1186/s12888-016-1117-x. PMID: 27863515. Exclusion Code: X3. [PMC free article: PMC5116169] [PubMed: 27863515] [CrossRef]
65.
de Bont PA, van den Berg DP, van der Vleugel BM, et al A multi-site single blind clinical study to compare the effects of prolonged exposure, eye movement desensitization and reprocessing and waiting list on patients with a current diagnosis of psychosis and co morbid post traumatic stress disorder: study protocol for the randomized controlled trial Treating Trauma in Psychosis. Trials. 2013 May 23;14:151. doi: 10.1186/1745-6215-14-151. PMID: 23702050. Exclusion Code: X6. [PMC free article: PMC3667059] [PubMed: 23702050] [CrossRef]
66.
de Bont PA, van Minnen A, de Jongh A. Treating PTSD in patients with psychosis: a within-group controlled feasibility study examining the efficacy and safety of evidence-based PE and EMDR protocols. Behav Ther. 2013 Dec;44(4):717–30. doi: 10.1016/j.beth.2013.07.002. PMID: 24094795. Exclusion Code: X2. [PubMed: 24094795] [CrossRef]
67.
de Haan KLB, Lee CW, Fassbinder E, et al Imagery rescripting and eye movement desensitisation and reprocessing for treatment of adults with childhood trauma-related post-traumatic stress disorder: IREM study design. BMC Psychiatry. 2017 2017-07-06;17(1) doi: http://dx​.doi.org/10​.1186/s12888-017-1330-2. PMID: 1916311878; 48079. Exclusion Code: X1. [PMC free article: PMC5418842] [PubMed: 28472933]
68.
Devilly GJ, Spence SH. The relative efficacy and treatment distress of EMDR and a cognitive-behavior trauma treatment protocol in the amelioration of posttraumatic stress disorder. J Anxiety Disord. 1999 Jan-Apr;13(1-2):131–57. PMID: 10225505. Exclusion Code: X2. [PubMed: 10225505]
69.
Dierks MR, Jordan JK, Sheehan AH. Prazosin treatment of nightmares related to posttraumatic stress disorder. Ann Pharmacother. 2016-09-15;41(6):1013–7. doi: http://dx​.doi.org/10.1345/aph.1H588. PMID: 42434359; 30286. Exclusion Code: X2. [PubMed: 17504838]
70.
Difede J, Cukor J, Jayasinghe N, et al Virtual reality exposure therapy for the treatment of posttraumatic stress disorder following September 11, 2001. J Clin Psychiatry. 2007 Nov;68(11):1639–47. PMID: 18052556. Exclusion Code: X2. [PubMed: 18052556]
71.
Dinnen S, Simiola V, Cook JM. Post-traumatic stress disorder in older adults: a systematic review of the psychotherapy treatment literature. Aging Ment Health. 2015;19(2):144–50. doi: 10.1080/13607863.2014.920299. PMID: 24898218. Exclusion Code: X2. [PubMed: 24898218] [CrossRef]
72.
Dodds AK. A treatment outcome study assessing the effectiveness of trauma focused and effect focused group psychotherapy for women who were sexually abused as children [dissertation]; 1996. Exclusion Code: X2.
73.
Dorrepaal E, Thomaes K, Hoogendoorn AW, et al Evidence-based treatment for adult women with child abuse-related complex PTSD: a quantitative review. European Journal of Psychotraumatology. 2016-09-15;5 doi: http://dx​.doi.org/10.3402/ejpt.v5.23613. PMID: 1645191247; 43107. Exclusion Code: X2. [PMC free article: PMC4199330] [PubMed: 25563302]
74.
Dossa N, Hatem M. Cognitive-behavioral therapy versus other PTSD psychotherapies as treatment for women victims of war-related violence: a systematic review (Provisional abstract). Scientific World Journal; 2012. Exclusion Code: X2. [PMC free article: PMC3345529] [PubMed: 22629120]
75.
Dossa NI, Hatem M. Cognitive-behavioral therapy versus other PTSD psychotherapies as treatment for women victims of war-related violence: a systematic review. ScientificWorldJournal. 2012;2012:181847. doi: 10.1100/2012/181847. PMID: 22629120. Exclusion Code: X2. [PMC free article: PMC3345529] [PubMed: 22629120] [CrossRef]
76.
Drozdek B, Kamperman AM, Bolwerk N, et al Group therapy with male asylum seekers and refugees with posttraumatic stress disorder: a controlled comparison cohort study of three day-treatment programs. J Nerv Ment Dis. 2012 Sep;200(9):758–65. doi: 10.1097/NMD.0b013e318266f860. PMID: 22922235. Exclusion Code: X2. [PubMed: 22922235] [CrossRef]
77.
Echeburua E, De Corral P, Sarasua B, et al Treatment of acute posttraumatic stress disorder in rape victims: An experimental study. J Anxiety Disord. 1996;10(3):185–99. Exclusion Code: X2.
78.
Echeburua E, de Corral P, Zubizarreta I, et al Psychological treatment of chronic posttraumatic stress disorder in victims of sexual aggression. Behav Modif. 1997 Oct;21(4):433–56. PMID: 9337600. Exclusion Code: X2. [PubMed: 9337600]
79.
Ehring T, Welboren R, Morina N, et al Meta-analysis of psychological treatments for posttraumatic stress disorder in adult survivors of childhood abuse. Clin Psychol Rev. 2014 Dec;34(8):645–57. doi: 10.1016/j.cpr.2014.10.004. PMID: 25455628. Exclusion Code: X2. [PubMed: 25455628] [CrossRef]
80.
Feinstein D. Acupoint stimulation in treating psychological disorders: Evidence of efficacy. Rev Gen Psychol. 2012;16(4):364–80. PMID: 108081845. Language: English. Entry Date: 20130208. Revision Date: 20150712. Publication Type: Journal Article. Exclusion Code: X2.
81.
Felmingham KL, Bryant RA. Gender differences in the maintenance of response to cognitive behavior therapy for posttraumatic stress disorder. J Consult Clin Psychol. 2012 Apr;80(2):196–200. doi: 10.1037/a0027156. PMID: 22309472. Exclusion Code: X2. [PubMed: 22309472] [CrossRef]
82.
Flanagan JC, Fischer MS, Badour CL, et al The role of relationship adjustment in an integrated individual treatment for PTSD and substance use disorders among veterans: an exploratory study. Journal of Dual Diagnosis. 2017 2017-07-06 doi: http://dx​.doi.org/10​.1080/15504263.2017.1312039. PMID: 1916312036; 48184. Exclusion Code: X5. [PMC free article: PMC5544565] [PubMed: 28541802]
83.
Foa EB, Asnaani A, Rosenfield D, et al Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: a randomized controlled trial. J Consult Clin Psychol. 2017 2017-09-05;85(9):862–72. doi: http://dx​.doi.org/10.1037/ccp0000213. PMID: 1935254594; 48569. Exclusion Code: X4. [PMC free article: PMC5578908] [PubMed: 28569519]
84.
Foa EB, Williams MT. Methodology of a randomized double-blind clinical trial for comorbid posttraumatic stress disorder and alcohol dependence. Mental Health and Substance Use: dual diagnosis. 2010;3(2):131–47. doi: 10.1080/17523281003738661. PMID: 2010-09375-006. Exclusion Code: X6. [PMC free article: PMC3431430] [PubMed: 22942892] [CrossRef]
85.
Foa EB, Yusko DA, McLean CP, et al Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA. 2013 Aug 07;310(5):488–95. doi: 10.1001/jama.2013.8268. PMID: 23925619. Exclusion Code: X4. [PubMed: 23925619] [CrossRef]
86.
Fortney JC, Pyne JM, Kimbrell TA, et al Telemedicine-based collaborative care for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Jan;72(1):58–67. doi: 10.1001/jamapsychiatry.2014.1575. PMID: 25409287. Exclusion Code: X4. [PubMed: 25409287] [CrossRef]
87.
Franciskovic T, Sukovic Z, Janovic S, et al Tianeptine in the combined treatment of combat related posttraumatic stress disorder. Psychiatr Danub. 2011 Sep;23(3):257–63. PMID: 21963693. Exclusion Code: X5. [PubMed: 21963693]
88.
Fredman SJ, Pukay-Martin ND, Macdonald A, et al Partner accommodation moderates treatment outcomes for couple therapy for posttraumatic stress disorder. J Consult Clin Psychol. 2016 Jan;84(1):79–87. doi: 10.1037/ccp0000061. PMID: 26501498. Exclusion Code: X6. [PMC free article: PMC4696059] [PubMed: 26501498] [CrossRef]
89.
Furuta M, Spain D, Bick D, et al Effectiveness of trauma-focused psychological therapies compared to usual postnatal care for treating post-traumatic stress symptoms in women following traumatic birth: a systematic review protocol. BMJ Open. 2017-02-02;6(11) doi: http://dx​.doi.org/10​.1136/bmjopen-2016-013697. PMID: 1863569194; 46302. Exclusion Code: X2. [PMC free article: PMC5168505] [PubMed: 27884855]
90.
Galano MM, Grogan-Kaylor AC, Stein SF, et al Posttraumatic stress disorder in Latina women: examining the efficacy of the Moms’ Empowerment Program. Psychological Trauma: Theory, Research, Practice, and Policy. 2017-03-01 doi: http://dx​.doi.org/10.1037/tra0000218. PMID: 1872797679; 46619. Exclusion Code: X3. [PubMed: 27869463]
91.
Gallagher MW, Resick PA. Mechanisms of change in cognitive processing therapy and prolonged exposure therapy for PTSD: preliminary evidence for the differential effects of hopelessness and habituation. Cognit Ther Res. 2016-09-15;36(6):750–5. doi: http://dx​.doi.org/10​.1007/s10608-011-9423-6. PMID: 1604424278; 42714. Exclusion Code: X5. [PMC free article: PMC3866807] [PubMed: 24363472]
92.
Gallegos AM, Wolff KB, Streltzov NA, et al Gender Differences in Service Utilization among OEF/OIF Veterans with Posttraumatic Stress Disorder after a Brief Cognitive-Behavioral Intervention to Increase Treatment Engagement: A Mixed Methods Study. Womens Health Issues. 2015 Sep-Oct;25(5):542–7. doi: 10.1016/j.whi.2015.04.008. PMID: 26051022. Exclusion Code: X2. [PMC free article: PMC4569511] [PubMed: 26051022] [CrossRef]
93.
Gapen MA, van der Kolk BA, Hamlin E, et al A pilot study of neurofeedback for chronic PTSD. Appl Psychophysiol Biofeedback. 2016-09-15;41(3):251–61. doi: http://dx​.doi.org/10​.1007/s10484-015-9326-5. PMID: 1793561055; 44803. Exclusion Code: X3. [PubMed: 26782083]
94.
Garland EL, Roberts-Lewis A, Tronnier CD, et al Mindfulness-Oriented Recovery Enhancement versus CBT for co-occurring substance dependence, traumatic stress, and psychiatric disorders: Proximal outcomes from a pragmatic randomized trial. Behav Res Ther. 2016 Feb;77:7–16. doi: 10.1016/j.brat.2015.11.012. PMID: 26701171. Exclusion Code: X3. [PMC free article: PMC4752876] [PubMed: 26701171] [CrossRef]
95.
Gawlytta R, Niemeyer H, Bottche M, et al Internet-based cognitive-behavioural writing therapy for reducing post-traumatic stress after intensive care for sepsis in patients and their spouses (REPAIR): study protocol for a randomised-controlled trial. BMJ Open. 2017-03-30;7(2) doi: http://dx​.doi.org/10​.1136/bmjopen-2016-014363. PMID: 1882073158; 47299. Exclusion Code: X6. [PMC free article: PMC5337733] [PubMed: 28232467]
96.
George A, Thilly N, Rydberg JA, et al Effectiveness of eye movement desensitization and reprocessing treatment in post-traumatic stress disorder after childbirth: a randomized controlled trial protocol. Acta Obstet Gynecol Scand. 2013 Jul;92(7):866–8. doi: 10.1111/aogs.12132. PMID: 23550534. Exclusion Code: X6. [PubMed: 23550534] [CrossRef]
97.
Gerger H, Munder T, Gemperli A, et al Integrating fragmented evidence by network meta-analysis: relative effectiveness of psychological interventions for adults with post-traumatic stress disorder. Psychol Med. 2016-09-15;44(15):3151–64. doi: http://dx​.doi.org/10​.1017/S0033291714000853. PMID: 1542295112; 42402. Exclusion Code: X2. [PubMed: 25066766]
98.
Germain A, Richardson R, Moul DE, et al Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans. J Psychosom Res. 2012 Feb;72(2):89–96. doi: 10.1016/j.jpsychores.2011.11.010. PMID: 22281448. Exclusion Code: X3. [PMC free article: PMC3267960] [PubMed: 22281448] [CrossRef]
99.
Gilmore AK, Davis MT, Grubaugh AL, et al “Do you expect me to receive PTSD care in a setting where most of the other patients remind me of the perpetrator?”: home-based telemedicine to address barriers to care unique to military sexual trauma and veterans affairs hospitals. Contemp Clin Trials. 2017-02-02;48:59–64. doi: http://dx​.doi.org/10​.1016/j.cct.2016.03.004. PMID: 1863569103; 46551. Exclusion Code: X6. [PMC free article: PMC4926870] [PubMed: 26992740]
100.
Gobin RL, Mackintosh M-A, Willis E, et al Predictors of differential PTSD treatment outcomes between veteran and civilian women after cognitive processing therapy. Psychological Trauma: Theory, Research, Practice, and Policy. 2017 2017-05-01 doi: http://dx​.doi.org/10.1037/tra0000266. PMID: 1893513815; 47673. Exclusion Code: X4. [PubMed: 28414493]
101.
Gorg N, Priebe K, Bohnke JR, et al Trauma-related emotions and radical acceptance in dialectical behavior therapy for posttraumatic stress disorder after childhood sexual abuse. Borderline Personality Disorder and Emotion Dysregulation. 2017 2017-09-05;4 doi: http://dx​.doi.org/10​.1186/s40479-017-0065-5. PMID: 1935254499; 48702. Exclusion Code: X6. [PMC free article: PMC5508787] [PubMed: 28717512]
102.
Gradus JL, Suvak MK, Wisco BE, et al Treatment of posttraumatic stress disorder reduces suicidal ideation. Depress Anxiety. 2013 Oct;30(10):1046–53. doi: 10.1002/da.22117. PMID: 23636925. Exclusion Code: X2. [PMC free article: PMC9040391] [PubMed: 23636925] [CrossRef]
103.
Graham-Bermann SA, Miller LE. Intervention to reduce traumatic stress following intimate partner violence: an efficacy trial of the Moms’ Empowerment Program (MEP). Psychodyn Psychiatry. 2013 Summer;41(2):329–49. doi: 10.1521/pdps.2013.41.2.329. PMID: 23713623. Exclusion Code: X2. [PubMed: 23713623] [CrossRef]
104.
Grote NK, Katon WJ, Russo JE, et al COLLABORATIVE CARE FOR PERINATAL DEPRESSION IN SOCIOECONOMICALLY DISADVANTAGED WOMEN: A RANDOMIZED TRIAL. Depress Anxiety. 2015 Nov;32(11):821–34. doi: 10.1002/da.22405. PMID: 26345179. Exclusion Code: X4. [PMC free article: PMC4630126] [PubMed: 26345179] [CrossRef]
105.
Gutermann J, Schreiber F, Matulis S, et al Psychological Treatments for Symptoms of Posttraumatic Stress Disorder in Children, Adolescents, and Young Adults: A Meta-Analysis. Clin Child Fam Psychol Rev. 2016 Jun;19(2):77–93. doi: 10.1007/s10567-016-0202-5. PMID: 27059619. Exclusion Code: X2. [PubMed: 27059619] [CrossRef]
106.
Gutner C, Suvak M, Sloan D, et al Does Timing Matter? Examining the Impact of Session Timing on Outcome. J Consult Clin Psychol; 2017. p. 1108–15. Exclusion Code: X5. [PMC free article: PMC5121088] [PubMed: 27213491]
107.
Gutner CA, Casement MD, Stavitsky Gilbert K, et al Change in sleep symptoms across Cognitive Processing Therapy and Prolonged Exposure: a longitudinal perspective. Behav Res Ther. 2013 Dec;51(12):817–22. doi: 10.1016/j.brat.2013.09.008. PMID: 24184428. Exclusion Code: X6. [PMC free article: PMC3849697] [PubMed: 24184428] [CrossRef]
108.
Hagl M, Powell S, Rosner R, et al Dialogical Exposure with Traumatically Bereaved Bosnian Women: Findings from a Controlled Trial. Clin Psychol Psychother. 2015 Nov-Dec;22(6):604–18. doi: 10.1002/cpp.1921. PMID: 25256361. Exclusion Code: X3. [PubMed: 25256361] [CrossRef]
109.
Han C, Pae C-U, Wang S-M, et al The potential role of atypical antipsychotics for the treatment of posttraumatic stress disorder. J Psychiatr Res. 2014;56:72–81. doi: 10.1016/j.jpsychires.2014.05.003. PMID: 2014-22844-001. Exclusion Code: X2. [PubMed: 24882700] [CrossRef]
110.
Hedman E, Ljotsson B, Lindefors N. Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost-effectiveness (Structured abstract). Expert Review of Pharmacoeconomics and Outcomes Research; 2012. p. 745–64. Exclusion Code: X2. [PubMed: 23252357]
111.
Held P, Owens GP. Effects of self-compassion workbook training on trauma-related guilt in a sample of homeless veterans: a pilot study. J Clin Psychol. 2015 Jun;71(6):513–26. doi: 10.1002/jclp.22170. PMID: 25820660. Exclusion Code: X3. [PubMed: 25820660] [CrossRef]
112.
Hertzberg MA, Moore SD, Feldman ME, et al A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2001 Feb;21(1):94–8. PMID: 11199956. Exclusion Code: X6. [PubMed: 11199956]
113.
Hetrick SE, Purcell R, Garner B, et al Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews: John Wiley < Sons, Ltd; 2010. Exclusion Code: X2. [PubMed: 20614457]
114.
Hien DA, Levin FR, Ruglass LM, et al Combining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trial. J Consult Clin Psychol. 2015 Apr;83(2):359–69. doi: 10.1037/a0038719. PMID: 25622199. Exclusion Code: X4. [PMC free article: PMC4380540] [PubMed: 25622199] [CrossRef]
115.
Hijazi AM, Lumley MA, Ziadni MS, et al Brief narrative exposure therapy for posttraumatic stress in Iraqi refugees: a preliminary randomized clinical trial. J Trauma Stress. 2014 Jun;27(3):314–22. doi: 10.1002/jts.21922. PMID: 24866253. Exclusion Code: X3. [PMC free article: PMC4080404] [PubMed: 24866253] [CrossRef]
116.
Hilton L, Maher AR, Colaiaco B, et al Meditation for posttraumatic stress disorder: a systematic review RAND Corporation. Exclusion Code: X2.
117.
Hobfoll SE, Blais RK, Stevens NR, et al Vets prevail online intervention reduces PTSD and depression in veterans with mild-to-moderate symptoms. J Consult Clin Psychol. 2016 Jan;84(1):31–42. doi: 10.1037/ccp0000041. PMID: 26322788. Exclusion Code: X3. [PubMed: 26322788] [CrossRef]
118.
Hoffart A, Øktedalen T, Langkaas TF. Self-compassion influences PTSD symptoms in the process of change in trauma-focused cognitive-behavioral therapies: a study of within-person processes. Front Psychol. 2016-09-28;6 doi: http://dx​.doi.org/10​.3389/fpsyg.2015.01273. PMID: 1823905107; 45369. Exclusion Code: X5. [PMC free article: PMC4551056] [PubMed: 26379596]
119.
Hoffart A, Øktedalen T, Langkaas TF, et al Alliance and outcome in varying imagery procedures for PTSD: a study of within-person processes. J Couns Psychol. 2016-09-15;60(4):471–82. doi: http://dx​.doi.org/10.1037/a0033604. PMID: 1700956140; 44042. Exclusion Code: X5. [PubMed: 23957768]
120.
Holliday R, Link-Malcolm J, Morris EE, et al Effects of cognitive processing therapy on PTSD-related negative cognitions in veterans with military sexual trauma. Mil Med. 2014 Oct;179(10):1077–82. doi: 10.7205/milmed-d-13-00309. PMID: 25269124. Exclusion Code: X6. [PubMed: 25269124] [CrossRef]
121.
Horesh D, Qian M, Freedman SA, et al Differential effect of exposure-based therapy and cognitive therapy on post-traumatic stress disorder symptom clusters: a randomized controlled trial. Psychology and Psychotherapy: Theory, Research and Practice. 2016-11-01 doi: http://dx​.doi.org/10.1111/papt.12103. PMID: 1834388710; 45483. Exclusion Code: X2. [PMC free article: PMC5326605] [PubMed: 27561944]
122.
Huhn M, Tardy M, Spineli LM, et al Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses. JAMA Psychiatry. 2016-09-15;71(6):706–15. doi: http://dx​.doi.org/10​.1001/jamapsychiatry.2014.112. PMID: 1532454772; 42261. Exclusion Code: X2. [PubMed: 24789675]
123.
Igreja V, Kleijn W, Schreuder B, et al Testimony method to ameliorate post-traumatic stress symptoms. Community-based intervention study with Mozambican civil war survivors. Br J Psychiatry; 2012. p. 251–7. Exclusion Code: X2. [PubMed: 14990524]
124.
Ipser JC, Stein DJ. Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). Int J Neuropsychopharmacol. 2012;15(6):825–40. doi: 10.1017/S1461145711001209. PMID: 2012-15845-009. Exclusion Code: X2. [PubMed: 21798109] [CrossRef]
125.
Ito M, Horikoshi M, Resick PA, et al Study protocol for a randomised controlled trial of cognitive processing therapy for post-traumatic stress disorder among Japanese patients: the Safety, Power, Intimacy, Esteem, Trust (SPINET) study. BMJ Open. 2017 2017-08-01;7(6):1. doi: http://dx​.doi.org/10​.1136/bmjopen-2016-014292. PMID: 1924870671; 48425. Exclusion Code: X1. [PMC free article: PMC5734443] [PubMed: 28667201]
126.
Iverson KM, King MW, Cunningham KC, et al Rape survivors’ trauma-related beliefs before and after Cognitive processing therapy: associations with PTSD and depression symptoms. Behav Res Ther. 2015 Mar;66:49–55. doi: 10.1016/j.brat.2015.01.002. PMID: 25698164. Exclusion Code: X6. [PubMed: 25698164] [CrossRef]
127.
Jacob N, Neuner F, Maedl A, et al Dissemination of psychotherapy for trauma spectrum disorders in postconflict settings: a randomized controlled trial in Rwanda. Psychother Psychosom. 2014;83(6):354–63. doi: 10.1159/000365114. PMID: 25323203. Exclusion Code: X6. [PubMed: 25323203] [CrossRef]
128.
Jain S, McMahon GF, Hasen P, et al Healing Touch with Guided Imagery for PTSD in returning active duty military: a randomized controlled trial. Mil Med. 2012 Sep;177(9):1015–21. PMID: 23025129. Exclusion Code: X4. [PubMed: 23025129]
129.
Jayawickreme N, Cahill SP, Riggs DS, et al Primum non nocere (first do no harm): symptom worsening and improvement in female assault victims after prolonged exposure for PTSD. Depress Anxiety. 2014 May;31(5):412–9. doi: 10.1002/da.22225. PMID: 24382682. Exclusion Code: X2. [PubMed: 24382682] [CrossRef]
130.
Jerud AB, Pruitt LD, Zoellner LA, et al The effects of prolonged exposure and sertraline on emotion regulation in individuals with posttraumatic stress disorder. Behav Res Ther. 2016;77:62–7. doi: 10.1016/j.brat.2015.12.002. PMID: 2016-07436-010. Exclusion Code: X2. [PMC free article: PMC4752860] [PubMed: 26723004] [CrossRef]
131.
Jerud AB, Zoellner LA, Pruitt LD, et al Changes in emotion regulation in adults with and without a history of childhood abuse following posttraumatic stress disorder treatment. J Consult Clin Psychol. 2014 Aug;82(4):721–30. doi: 10.1037/a0036520. PMID: 24708349. Exclusion Code: X6. [PMC free article: PMC4115012] [PubMed: 24708349] [CrossRef]
132.
Jonas D, Cusack K, Forneris C, et al Comparative effectiveness of psychological treatments and pharmacological treatments for adults with posttraumatic stress disorder (PTSD) (Structured abstract). Health Technology Assessment Database: Agency for Healthcare Research and Quality (AHRQ); 2013. Exclusion Code: X2. [PubMed: 23658937]
133.
Jonas D, Cusack K, Forneris C, et al Psychological and pharmacological treatments for adults with posttraumatic stress disorder (PTSD) (Provisional abstract). Database of Abstracts of Reviews of Effects: Agency for Healthcare Research and Quality; 2013. Exclusion Code: X2. [PubMed: 23658937]
134.
Jun JJ, Zoellner LA, Feeny NC. Sudden gains in prolonged exposure and sertraline for chronic PTSD. Depress Anxiety. 2013 Jul;30(7):607–13. doi: 10.1002/da.22119. PMID: 23633445. Exclusion Code: X6. [PMC free article: PMC3930488] [PubMed: 23633445] [CrossRef]
135.
Jung K, Steil R. A randomized controlled trial on cognitive restructuring and imagery modification to reduce the feeling of being contaminated in adult survivors of childhood sexual abuse suffering from posttraumatic stress disorder. Psychother Psychosom. 2013;82(4):213–20. doi: 10.1159/000348450. PMID: 23712073. Exclusion Code: X4. [PubMed: 23712073] [CrossRef]
136.
Kaczkurkin AN, Asnaani A, Alpert E, et al The impact of treatment condition and the lagged effects of PTSD symptom severity and alcohol use on changes in alcohol craving. Behav Res Ther. 2016 Apr;79:7–14. doi: 10.1016/j.brat.2016.02.001. PMID: 26905901. Exclusion Code: X6. [PMC free article: PMC4801783] [PubMed: 26905901] [CrossRef]
137.
Kangas M, Milross C, Taylor A, et al A pilot randomized controlled trial of a brief early intervention for reducing posttraumatic stress disorder, anxiety and depressive symptoms in newly diagnosed head and neck cancer patients. Psychooncology. 2013 Jul;22(7):1665–73. doi: 10.1002/pon.3208. PMID: 23042612. Exclusion Code: X3. [PubMed: 23042612] [CrossRef]
138.
Kasckow J, Morse J, Begley A, et al Treatment of post traumatic stress disorder symptoms in emotionally distressed individuals. Psychiatry Res. 2014 Dec 15;220(1-2):370–5. doi: 10.1016/j.psychres.2014.06.043. PMID: 25107318. Exclusion Code: X3. [PMC free article: PMC4253016] [PubMed: 25107318] [CrossRef]
139.
Katz L, Douglas S, Zaleski K, et al Comparing holographic reprocessing and prolonged exposure for women veterans with sexual trauma: A pilot randomized trial. Journal of contemporary psychotherapy; 2014. p. 9–19. Exclusion Code: X4.
140.
Kehle-Forbes SM, Drapkin ML, Foa EB, et al Study design, interventions, and baseline characteristics for the Substance use and TRauma Intervention for VEterans (STRIVE) trial. Contemp Clin Trials. 2016-09-28;50:45–53. doi: http://dx​.doi.org/10​.1016/j.cct.2016.07.017. PMID: 1823905324; 45356. Exclusion Code: X6. [PMC free article: PMC9873310] [PubMed: 27444425]
141.
Kellner M, Muhtz C, Wiedemann K. Primary add-on of ziprasidone in sertraline treatment of posttraumatic stress disorder: lessons from a stopped trial? J Clin Psychopharmacol. 2010 Aug;30(4):471–3. doi: 10.1097/JCP.0b013e3181e79600. PMID: 20631571. Exclusion Code: X2. [PubMed: 20631571] [CrossRef]
142.
Kersting A, Dolemeyer R, Steinig J, et al Brief Internet-based intervention reduces posttraumatic stress and prolonged grief in parents after the loss of a child during pregnancy: a randomized controlled trial. Psychother Psychosom. 2013;82(6):372–81. doi: 10.1159/000348713. PMID: 24061387. Exclusion Code: X3. [PubMed: 24061387] [CrossRef]
143.
Khachatryan D, Groll D, Booij L, et al Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials. Gen Hosp Psychiatry. 2016 Mar-Apr;39:46–52. doi: 10.1016/j.genhosppsych.2015.10.007. PMID: 26644317. Exclusion Code: X2. [PubMed: 26644317] [CrossRef]
144.
Khazaie H, Nasouri M, Ghadami M. Prazosin for trauma nightmares and sleep disturbances in combat veterans with post-traumatic stress disorder. Iranian journal of psychiatry and behavioral sciences; 2017. Exclusion Code: X6. [PMC free article: PMC5097449] [PubMed: 27822278]
145.
King AP, Erickson TM, Giardino ND, et al A pilot study of group mindfulness-based cognitive therapy (MBCT) for combat veterans with posttraumatic stress disorder (PTSD). Depress Anxiety. 2013 Jul;30(7):638–45. doi: 10.1002/da.22104. PMID: 23596092. Exclusion Code: X2. [PMC free article: PMC4373594] [PubMed: 23596092] [CrossRef]
146.
Kip KE, Elk CA, Sullivan KL, et al Brief treatment of symptoms of post-traumatic stress disorder (PTSD) by use of accelerated resolution therapy (ART). Behavioral Sciences. 2016-09-15;2(2):115–34. doi: http://dx​.doi.org/10.3390/bs2020115. PMID: 1520733532; 42049. Exclusion Code: X3. [PMC free article: PMC4217580] [PubMed: 25379218]
147.
Kip KE, Rosenzweig L, Hernandez DF, et al Accelerated resolution therapy for treatment of pain secondary to symptoms of combat-related posttraumatic stress disorder. European Journal of Psychotraumatology. 2016-09-15;5 doi: http://dx​.doi.org/10.3402/ejpt.v5.24066. PMID: 1552590483; 42537. Exclusion Code: X6. [PMC free article: PMC4014659] [PubMed: 24959325]
148.
Kip KE, Rosenzweig L, Hernandez DF, et al Randomized controlled trial of accelerated resolution therapy (ART) for symptoms of combat-related post-traumatic stress disorder (PTSD). Mil Med. 2013 Dec;178(12):1298–309. doi: 10.7205/milmed-d-13-00298. PMID: 24306011. Exclusion Code: X7. [PubMed: 24306011] [CrossRef]
149.
Kok T, de Haan HA, van der Meer M, et al Efficacy of “seeking safety” in a Dutch population of traumatized substance-use disorder outpatients: study protocol of a randomized controlled trial. BMC Psychiatry. 2013 Jun 04;13:162. doi: 10.1186/1471-244x-13-162. PMID: 23735118. Exclusion Code: X6. [PMC free article: PMC3679962] [PubMed: 23735118] [CrossRef]
150.
Korte KJ, Bountress KE, Tomko RL, et al Integrated treatment of PTSD and substance use disorders: the mediating role of PTSD improvement in the reduction of depression. Journal of Clinical Medicine. 2017 2017-05-01;6(1) doi: http://dx​.doi.org/10.3390/jcm6010009. PMID: 1893513830; 47589. Exclusion Code: X5. [PMC free article: PMC5294962] [PubMed: 28098747]
151.
Kosten TR, Frank JB, Dan E, et al Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991 Jun;179(6):366–70. PMID: 2051152. Exclusion Code: X4. [PubMed: 2051152]
152.
Kruger A, Ehring T, Priebe K, et al Sudden losses and sudden gains during a DBT-PTSD treatment for posttraumatic stress disorder following childhood sexual abuse. European Journal of Psychotraumatology. 2016-09-15;5 doi: http://dx​.doi.org/10.3402/ejpt.v5.24470. PMID: 1645188168; 43109. Exclusion Code: X7. [PMC free article: PMC4168314] [PubMed: 25317254]
153.
Kruger A, Kleindienst N, Priebe K, et al Non-suicidal self-injury during an exposure-based treatment in patients with posttraumatic stress disorder and borderline features. Behav Res Ther. 2014 Oct;61:136–41. doi: 10.1016/j.brat.2014.08.003. PMID: 25193004. Exclusion Code: X5. [PubMed: 25193004] [CrossRef]
154.
Krupnick JL, Green BL, Amdur RL, et al An internet-based writing intervention for PTSD in veterans: a feasibility and pilot effectiveness trial. Psychological Trauma: Theory, Research, Practice, and Policy. 2016-12-01 doi: http://dx​.doi.org/10.1037/tra0000176. PMID: 1844925484; 45679. Exclusion Code: X3. [PubMed: 27607767]
155.
Kruse J, Joksimovic L, Cavka M, et al Effects of trauma-focused psychotherapy upon war refugees. J Trauma Stress. 2009 Dec;22(6):585–92. doi: 10.1002/jts.20477. PMID: 19960519. Exclusion Code: X2. [PubMed: 19960519] [CrossRef]
156.
Krystal JH, Pietrzak RH, Rosenheck RA, et al Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs Cooperative Study #504. J Clin Psychiatry. 2016-09-15;77(4):483–91. doi: http://dx​.doi.org/10.4088/JCP.14m09585. PMID: 1793561068; 44673. Exclusion Code: X6. [PubMed: 26890894]
157.
Kuckertz JM, Amir N, Boffa JW, et al The effectiveness of an attention bias modification program as an adjunctive treatment for Post-Traumatic Stress Disorder. Behav Res Ther. 2014 Dec;63:25–35. doi: 10.1016/j.brat.2014.09.002. PMID: 25277496. Exclusion Code: X5. [PMC free article: PMC4258474] [PubMed: 25277496] [CrossRef]
158.
Lambert JE, Alhassoon OM. Trauma-focused therapy for refugees: meta-analytic findings. J Couns Psychol. 2015 Jan;62(1):28–37. doi: 10.1037/cou0000048. PMID: 25485547. Exclusion Code: X2. [PubMed: 25485547] [CrossRef]
159.
Larsen SE, Stirman SW, Smith BN, et al Symptom exacerbations in trauma-focused treatments: associations with treatment outcome and non-completion. Behav Res Ther. 2016-09-15;77:68–77. doi: http://dx​.doi.org/10​.1016/j.brat.2015.12.009. PMID: 1800697495; 44662. Exclusion Code: X5. [PubMed: 26731171]
160.
Le Q, Doctor J, Zoellner L, et al Cost-effectiveness of prolonged exposure therapy versus pharmacotherapy and treatment choice in posttraumatic stress disorder (the optimizing PTSD treatment trial): a doubly randomized preference trial (Provisional abstract). J Clin Psychiatry; 2014. p. 222–30. Exclusion Code: X6. [PubMed: 24717377]
161.
Le QA, Doctor JN, Zoellner LA, et al Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT). Health Qual Life Outcomes. 2013 Apr 12;11:59. doi: 10.1186/1477-7525-11-59. PMID: 23587015. Exclusion Code: X6. [PMC free article: PMC3635945] [PubMed: 23587015] [CrossRef]
162.
Le QA, Doctor JN, Zoellner LA, et al Cost-effectiveness of prolonged exposure therapy versus pharmacotherapy and treatment choice in posttraumatic stress disorder (the Optimizing PTSD Treatment Trial): a doubly randomized preference trial. J Clin Psychiatry. 2014 Mar;75(3):222–30. doi: 10.4088/JCP.13m08719. PMID: 24717377. Exclusion Code: X6. [PubMed: 24717377] [CrossRef]
163.
Lee DJ, Schnitzlein CW, Wolf JP, et al Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: systemic review and meta-analyses to determine first-line treatments. Depress Anxiety. 2016-12-21;33(9):792–806. doi: http://dx​.doi.org/10.1002/da.22511. PMID: 1807271125; 44832. Exclusion Code: X2. [PubMed: 27126398]
164.
Lee DJ, Schnitzlein CW, Wolf JP, et al Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: Systemic review and meta-analyses to determine first-line treatments. Depress Anxiety. 2016;33(9):792–806. doi: 10.1002/da.22511. PMID: 2016-43177-002. Exclusion Code: X2. [PubMed: 27126398] [CrossRef]
165.
Lehavot K, Litz B, Millard S, et al Study adaptation, design, and methods of a web-based PTSD intervention for women Veterans. Contemp Clin Trials; 2017. p. 68–79. Exclusion Code: X6. [PubMed: 27940187]
166.
Leigh-Hunt N, Perry A. A systematic review of interventions for anxiety, depression, and PTSD in adult offenders (Provisional abstract). Int J Offender Ther Comp Criminol; 2014. p. epub. Exclusion Code: X2. [PubMed: 24441030]
167.
Leigh-Hunt N, Perry A. A systematic review of interventions for anxiety, depression, and PTSD in adult offenders. Int J Offender Ther Comp Criminol. 2015 Jun;59(7):701–25. doi: 10.1177/0306624x13519241. PMID: 24441030. Exclusion Code: X2. [PubMed: 24441030] [CrossRef]
168.
Leiner AS, Kearns MC, Jackson JL, et al Avoidant coping and treatment outcome in rape-related posttraumatic stress disorder. J Consult Clin Psychol. 2012 Apr;80(2):317–21. doi: 10.1037/a0026814. PMID: 22229757. Exclusion Code: X2. [PMC free article: PMC3314118] [PubMed: 22229757] [CrossRef]
169.
Levi O, Bar-Haim Y, Kreiss Y, et al Cognitive-behavioural therapy and psychodynamic psychotherapy in the treatment of combat-related post-traumatic stress disorder: a comparative effectiveness study. Clinical Psychology and Psychotherapy. 2017-02-27;23(4):298–307. doi: http://dx​.doi.org/10.1002/cpp.1969. PMID: 1708519710; 44241. Exclusion Code: X2. [PubMed: 26189337]
170.
Lewis C, Roberts NP, Bethell A, et al Internet-based cognitive and behavioural therapies for post-traumatic stress disorder (PTSD) in adults. Cochrane Database of Systematic Reviews: John Wiley < Sons, Ltd; 2015. Exclusion Code: X2. [PMC free article: PMC6516951] [PubMed: 30550643]
171.
Lewis CE, Farewell D, Groves V, et al Internet-based guided self-help for posttraumatic stress disorder (PTSD): randomized controlled trial. Depress Anxiety. 2017 2017-07-06;34(6):555–65. doi: http://dx​.doi.org/10.1002/da.22645. PMID: 1916303328; 48301. Exclusion Code: X4. [PubMed: 28557299]
172.
Liedl A, Muller J, Morina N, et al Physical activity within a CBT intervention improves coping with pain in traumatized refugees: results of a randomized controlled design. Pain Med. 2011 Feb;12(2):234–45. doi: 10.1111/j.1526-4637.2010.01040.x. PMID: 21223501. Exclusion Code: X12. [PubMed: 21223501] [CrossRef]
173.
Litz BT, Salters-Pedneault K, Steenkamp MM, et al A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res. 2012 Sep;46(9):1184–90. doi: 10.1016/j.jpsychires.2012.05.006. PMID: 22694905. Exclusion Code: X4. [PubMed: 22694905] [CrossRef]
174.
Liu X-h, Xie X-h, Wang K-y, et al Efficacy and acceptability of atypical antipsychotics for the treatment of post-traumatic stress disorder: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Psychiatry Res. 2014;219(3):543–9. doi: 10.1016/j.psychres.2014.05.027. PMID: 2014-28727-001. Exclusion Code: X2. [PubMed: 25015709] [CrossRef]
175.
Liverant GI, Suvak MK, Pineles SL, et al Changes in posttraumatic stress disorder and depressive symptoms during cognitive processing therapy: evidence for concurrent change. J Consult Clin Psychol. 2012 Dec;80(6):957–67. doi: 10.1037/a0030485. PMID: 23067427. Exclusion Code: X5. [PubMed: 23067427] [CrossRef]
176.
Lopes AP, Macedo TF, Coutinho ESF, et al Systematic review of the efficacy of cognitive-behavior therapy related treatments for victims of natural disasters: a worldwide problem. PLoS One. 2016-09-15;9(10) doi: http://dx​.doi.org/10​.1371/journal.pone.0109013. PMID: 1708514423; 44215. Exclusion Code: X2. [PMC free article: PMC4189911] [PubMed: 25296020]
177.
Lopez CM, Lancaster CL, Gros DF, et al Residual sleep problems predict reduced response to prolonged exposure among veterans with PTSD. Journal of Psychopathology and Behavioral Assessment. 2017 2017-09-05 doi: http://dx​.doi.org/10​.1007/s10862-017-9618-6. PMID: 1935254450; 48707. Exclusion Code: X5. [PMC free article: PMC5716480] [PubMed: 29225414]
178.
Lunney CA, Schnurr PP, Cook JM. Comparison of clinician- and self-assessments of posttraumatic stress symptoms in older versus younger veterans. J Trauma Stress. 2016-09-15;27(2):144–51. doi: http://dx​.doi.org/10.1002/jts.21908. PMID: 1520733711; 42063. Exclusion Code: X4. [PubMed: 24700623]
179.
Macdonald A, Pukay-Martin ND, Wagner AC, et al Cognitive-behavioral conjoint therapy for PTSD improves various PTSD symptoms and trauma-related cognitions: Results from a randomized controlled trial. J Fam Psychol. 2016 Feb;30(1):157–62. doi: 10.1037/fam0000177. PMID: 26651352. Exclusion Code: X6. [PMC free article: PMC4749018] [PubMed: 26651352] [CrossRef]
180.
Maercker A, Zöllner T, Menning H, et al Dresden PTSD treatment study: randomized controlled trial of motor vehicle accident survivors. BMC Psychiatry; 2012. p. 29. Exclusion Code: X3. [PMC free article: PMC1543618] [PubMed: 16824221]
181.
Maieritsch KP, Smith TL, Hessinger JD, et al Randomized controlled equivalence trial comparing videoconference and in person delivery of cognitive processing therapy for PTSD. J Telemed Telecare. 2016-09-15;22(4):238–43. doi: http://dx​.doi.org/10​.1177/1357633x15596109. PMID: 1812432822; 45182. Exclusion Code: X5. [PubMed: 26231819]
182.
Malik ML, Connor KM, Sutherland SM, et al Quality of life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine. J Trauma Stress. 1999 Apr;12(2):387–93. doi: 10.1023/a:1024745030140. PMID: 10378176. Exclusion Code: X2. [PubMed: 10378176] [CrossRef]
183.
Markowitz JC, Petkova E, Biyanova T, et al EXPLORING PERSONALITY DIAGNOSIS STABILITY FOLLOWING ACUTE PSYCHOTHERAPY FOR CHRONIC POSTTRAUMATIC STRESS DISORDER. Depress Anxiety. 2015 Dec;32(12):919–26. doi: 10.1002/da.22436. PMID: 26439430. Exclusion Code: X5. [PMC free article: PMC4674381] [PubMed: 26439430] [CrossRef]
184.
Martenyi F, Brown EB, Zhang H, et al Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. Br J Psychiatry. 2002 Oct;181:315–20. PMID: 12356658. Exclusion Code: X3. [PubMed: 12356658]
185.
Mataix-Cols D, Fernández de la Cruz L, Monzani B, et al D-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: A systematic review and meta-analysis of individual participant data. JAMA Psychiatry. 2017;74(5):501–10. doi: 10.1001/jamapsychiatry.2016.3955. PMID: 2017-32659-007. Exclusion Code: X4. [PubMed: 28122091] [CrossRef]
186.
McHugh RK, Hu MC, Campbell AN, et al Changes in sleep disruption in the treatment of co-occurring posttraumatic stress disorder and substance use disorders. J Trauma Stress. 2014 Feb;27(1):82–9. doi: 10.1002/jts.21878. PMID: 24473926. Exclusion Code: X6. [PMC free article: PMC4096867] [PubMed: 24473926] [CrossRef]
187.
McLay RN, Baird A, Webb-Murphy J, et al A Randomized, Head-to-Head Study of Virtual Reality Exposure Therapy for Posttraumatic Stress Disorder. Cyberpsychol Behav Soc Netw. 2017 Apr;20(4):218–24. doi: 10.1089/cyber.2016.0554. PMID: 28394217. Exclusion Code: X5. [PubMed: 28394217] [CrossRef]
188.
McLean CP, Su YJ, Foa EB. Mechanisms of symptom reduction in a combined treatment for comorbid posttraumatic stress disorder and alcohol dependence. J Consult Clin Psychol. 2015 Jun;83(3):655–61. doi: 10.1037/ccp0000024. PMID: 26009787. Exclusion Code: X3. [PMC free article: PMC4445454] [PubMed: 26009787] [CrossRef]
189.
McPherson J. Does Narrative Exposure Therapy Reduce PTSD in Survivors of Mass Violence? Research on Social Work Practice. 2012;22(1):29–42. doi: 10.1177/1049731511414147. PMID: 104620857. Language: English. Entry Date: 20120131. Revision Date: 20150711. Publication Type: Journal Article. Exclusion Code: X2. [CrossRef]
190.
Meffert SM, Abdo AO, Alia OAA, et al A Pilot Randomized Controlled Trial of Interpersonal Psychotherapy for Sudanese Refugees in Cairo, Egypt. Psychol Trauma. 2014;6(3):240–9. doi: 10.1037/a0023540. PMID: 107850648. Language: English. Entry Date: 20140709. Revision Date: 20150712. Publication Type: Journal Article. Exclusion Code: X3. [CrossRef]
191.
Meier A, McGovern MP, Lambert-Harris C, et al Adherence and competence in two manual-guided therapies for co-occurring substance use and posttraumatic stress disorders: clinician factors and patient outcomes. Am J Drug Alcohol Abuse. 2015;41(6):527–34. doi: 10.3109/00952990.2015.1062894. PMID: 26286351. Exclusion Code: X6. [PMC free article: PMC4698972] [PubMed: 26286351] [CrossRef]
192.
Mello M, Yeh M, Barbosa NJ, et al A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder. BMC Psychiatry; 2012. p. 28. Exclusion Code: X6. [PMC free article: PMC2698902] [PubMed: 19480669]
193.
Mello P, Silva G, Donat J, et al An update on the efficacy of cognitive-behavioral therapy, cognitive therapy, and exposure therapy for posttraumatic stress disorder (Provisional abstract). Database of Abstracts of Reviews of Effects; 2013. p. 339–57. Exclusion Code: X2. [PubMed: 24922986]
194.
Metcalf O, Varker T, Forbes D, et al Efficacy of fifteen emerging interventions for the treatment of posttraumatic stress disorder: a systematic review. J Trauma Stress. 2016-09-15;29(1):88–92. doi: http://dx​.doi.org/10.1002/jts.22070. PMID: 1800696293; 44657. Exclusion Code: X2. [PubMed: 26749196]
195.
Middleton K, Craig CD. A Systematic Literature Review of PTSD Among Female Veterans From 1990 to 2010. Social Work in Mental Health. 2012;10(3):233–52. doi: 10.1080/15332985.2011.639929. PMID: 104537412. Language: English. Entry Date: 20120419. Revision Date: 20150820. Publication Type: Journal Article. Exclusion Code: X2. [CrossRef]
196.
Miles SR, Smith TL, Maieritsch KP, et al Fear of Losing Emotional Control Is Associated With Cognitive Processing Therapy Outcomes in U.S. Veterans of Afghanistan and Iraq. J Trauma Stress. 2015 Oct;28(5):475–9. doi: 10.1002/jts.22036. PMID: 26397721. Exclusion Code: X2. [PubMed: 26397721] [CrossRef]
197.
Mills AC, Badour CL, Korte KJ, et al Integrated treatment of PTSD and substance use disorders: examination of imaginal exposure length. J Trauma Stress. 2017 2017-06-01;30(2):166–72. doi: http://dx​.doi.org/10.1002/jts.22175. PMID: 1904190737; 47719. Exclusion Code: X5. [PMC free article: PMC5507581] [PubMed: 28329434]
198.
Mills KL, Barrett EL, Merz S, et al Integrated exposure-based therapy for co-occurring post traumatic stress disorder (PTSD) and substance dependence: predictors of change in PTSD symptom severity. Journal of Clinical Medicine. 2017-02-02;5(11) doi: http://dx​.doi.org/10.3390/jcm5110101. PMID: 1863569144; 46312. Exclusion Code: X5. [PMC free article: PMC5126798] [PubMed: 27854264]
199.
Miner A, Kuhn E, Hoffman JE, et al Feasibility, acceptability, and potential efficacy of the PTSD Coach app: a pilot randomized controlled trial with community trauma survivors. Psychological Trauma: Theory, Research, Practice, and Policy. 2016-12-01;8(3):384–92. doi: http://dx​.doi.org/10.1037/tra0000092. PMID: 1844925309; 44676. Exclusion Code: X3. [PubMed: 27046668]
200.
Mitchell KS, Wells SY, Mendes A, et al Treatment improves symptoms shared by PTSD and disordered eating. J Trauma Stress. 2016-09-15;25(5):535–42. doi: http://dx​.doi.org/10.1002/jts.21737. PMID: 1125212835; 87062. Exclusion Code: X5. [PubMed: 23073973]
201.
Miyahira SD, Folen RA, Hoffman HG, et al The effectiveness of VR exposure therapy for PTSD in returning warfighters. Stud Health Technol Inform. 2012;181:128–32. PMID: 22954842. Exclusion Code: X3. [PubMed: 22954842]
202.
Morgan-Lopez AA, Saavedra LM, Hien DA, et al Indirect effects of 12-session seeking safety on substance use outcomes: overall and attendance class-specific effects. Am J Addict. 2014 May-Jun;23(3):218–25. doi: 10.1111/j.1521-0391.2014.12100.x. PMID: 24724878. Exclusion Code: X6. [PubMed: 24724878] [CrossRef]
203.
Morina N, Malek M, Nickerson A, et al Meta-analysis of interventions for posttraumatic stress disorder and depression in adult survivors of mass violence in low- and middle-income countries. Depress Anxiety. 2017 2017-06-01 doi: http://dx​.doi.org/10.1002/da.22618. PMID: 1904191244; 47990. Exclusion Code: X2. [PubMed: 28419625]
204.
Morina N, Wicherts JM, Lobbrecht J, et al Remission from post-traumatic stress disorder in adults: a systematic review and meta-analysis of long term outcome studies. Clin Psychol Rev. 2014 Apr;34(3):249–55. doi: 10.1016/j.cpr.2014.03.002. PMID: 24681171. Exclusion Code: X2. [PubMed: 24681171] [CrossRef]
205.
Morland L, Greene C, Rosen C, et al Telemedicine for anger management therapy in a rural population of combat veterans with posttraumatic stress disorder: a randomized noninferiority trial. J Clin Psychiatry; 2012. p. 855–63. Exclusion Code: X5. [PubMed: 20122374]
206.
Mullen K, Holliday R, Morris E, et al Cognitive processing therapy for male veterans with military sexual trauma-related posttraumatic stress disorder. J Anxiety Disord. 2014 Dec;28(8):761–4. doi: 10.1016/j.janxdis.2014.09.004. PMID: 25260214. Exclusion Code: X2. [PubMed: 25260214] [CrossRef]
207.
Mundt AP, Wünsche P, Heinz A, et al Evaluating interventions for posttraumatic stress disorder in low and middle income countries: Narrative Exposure Therapy. Intervention (15718883). 2014;12(2):250–66. PMID: 107866219. Language: English. Entry Date: 20140725. Revision Date: 20150712. Publication Type: Journal Article. Exclusion Code: X2.
208.
Myers US, Browne KC, Norman SB. Treatment engagement: female survivors of intimate partner violence in treatment for PTSD and alcohol use disorder. Journal of Dual Diagnosis. 2016-09-15;11(3-4):238–47. doi: http://dx​.doi.org/10​.1080/15504263.2015.1113762. PMID: 1800697460; 44854. Exclusion Code: X6. [PMC free article: PMC4915366] [PubMed: 26515712]
209.
Nacasch N, Huppert JD, Su YJ, et al Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? A randomized noninferiority clinical trial. Behav Ther. 2015 May;46(3):328–41. doi: 10.1016/j.beth.2014.12.002. PMID: 25892169. Exclusion Code: X4. [PubMed: 25892169] [CrossRef]
210.
Naylor JC, Dolber TR, Strauss JL, et al A pilot randomized controlled trial with paroxetine for subthreshold PTSD in Operation Enduring Freedom/Operation Iraqi Freedom era veterans. Psychiatry Res. 2013 Apr 30;206(2-3):318–20. doi: 10.1016/j.psychres.2012.11.008. PMID: 23276723. Exclusion Code: X3. [PMC free article: PMC3788578] [PubMed: 23276723] [CrossRef]
211.
Nenova M, Morris L, Paul L, et al Psychosocial Interventions With Cognitive-Behavioral Components for the Treatment of Cancer-Related Traumatic Stress Symptoms: A Review of Randomized Controlled Trials. J Cogn Psychother. 2013;27(3):258–84. doi: 10.1891/0889-8391.27.3.258. PMID: 107968193. Language: English. Entry Date: 20130904. Revision Date: 20150712. Publication Type: Journal Article. Exclusion Code: X2. [PubMed: 32759144] [CrossRef]
212.
Nidich S, Seng A, Compton B, et al Transcendental Meditation and Reduced Trauma Symptoms in Female Inmates: A Randomized Controlled Study. Perm J. 2017;21 doi: 10.7812/tpp/16-008. PMID: 28333611. Exclusion Code: X3. [PMC free article: PMC5363900] [PubMed: 28333611] [CrossRef]
213.
Nijdam MJ, de Vries GJ, Gersons BP, et al Response to psychotherapy for posttraumatic stress disorder: the role of pretreatment verbal memory performance. J Clin Psychiatry. 2015 Aug;76(8):e1023–8. doi: 10.4088/JCP.14m09438. PMID: 26335088. Exclusion Code: X5. [PubMed: 26335088] [CrossRef]
214.
Nijdam MJ, van Amsterdam JG, Gersons BP, et al Dexamethasone-suppressed cortisol awakening response predicts treatment outcome in posttraumatic stress disorder. J Affect Disord. 2015 Sep 15;184:205–8. doi: 10.1016/j.jad.2015.05.058. PMID: 26112329. Exclusion Code: X2. [PubMed: 26112329] [CrossRef]
215.
Niles BL, Vujanovic AA, Silberbogen AK, et al Changes in mindfulness following a mindfulness telehealth intervention. Mindfulness. 2016-09-15;4(4):301–10. doi: http://dx​.doi.org/10​.1007/s12671-012-0130-5. PMID: 1667950989; 43503. Exclusion Code: X6.
216.
Nixon RD. Cognitive processing therapy versus supportive counseling for acute stress disorder following assault: a randomized pilot trial. Behav Ther. 2012 Dec;43(4):825–36. doi: 10.1016/j.beth.2012.05.001. PMID: 23046784. Exclusion Code: X3. [PubMed: 23046784] [CrossRef]
217.
Nosè M, Ballette F, Bighelli I, et al Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: systematic review and meta-analysis. PLoS One. 2017 2017-05-01;12(2) doi: http://dx​.doi.org/10​.1371/journal.pone.0171030. PMID: 1893513906; 47469. Exclusion Code: X2. [PMC free article: PMC5289495] [PubMed: 28151992]
218.
Nosen E, Littlefield AK, Schumacher JA, et al Treatment of co-occurring PTSD-AUD: effects of exposure-based and non-trauma focused psychotherapy on alcohol and trauma cue-reactivity. Behav Res Ther. 2014 Oct;61:35–42. doi: 10.1016/j.brat.2014.07.003. PMID: 25127178. Exclusion Code: X6. [PMC free article: PMC4188412] [PubMed: 25127178] [CrossRef]
219.
O’Donnell ML, Lau W, Tipping S, et al Stepped early psychological intervention for posttraumatic stress disorder, other anxiety disorders, and depression following serious injury. J Trauma Stress. 2012 Apr;25(2):125–33. doi: 10.1002/jts.21677. PMID: 22522725. Exclusion Code: X3. [PubMed: 22522725] [CrossRef]
220.
Oehen P, Traber R, Widmer V, et al A randomized, controlled pilot study of MDMA (+/− 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). J Psychopharmacol. 2013 Jan;27(1):40–52. doi: 10.1177/0269881112464827. PMID: 23118021. Exclusion Code: X4. [PubMed: 23118021] [CrossRef]
221.
Oktedalen T, Hoffart A, Langkaas TF. Trauma-related shame and guilt as time-varying predictors of posttraumatic stress disorder symptoms during imagery exposure and imagery rescripting--A randomized controlled trial. Psychother Res. 2015;25(5):518–32. doi: 10.1080/10503307.2014.917217. PMID: 24856364. Exclusion Code: X5. [PubMed: 24856364] [CrossRef]
222.
Omidi A, Mohammadi A, Zargar F, et al Efficacy of mindfulness-based stress reduction on mood states of veterans with post-traumatic stress disorder. Archives of Trauma Research. 2017-03-30;1(4):151–4. doi: http://dx​.doi.org/10.5812/atr.8226. PMID: 1882073151; 46951. Exclusion Code: X6. [PMC free article: PMC3876494] [PubMed: 24396769]
223.
Onder E, Tural U, Aker T. A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake. Eur Psychiatry. 2006 Apr;21(3):174–9. doi: 10.1016/j.eurpsy.2005.03.007. PMID: 15964747. Exclusion Code: X2. [PubMed: 15964747] [CrossRef]
224.
Onu C, Ongeri L, Bukusi E, et al Interpersonal psychotherapy for depression and posttraumatic stress disorder among HIV-positive women in Kisumu, Kenya: study protocol for a randomized controlled trial. Trials. 2016-10-25;17(1) doi: http://dx​.doi.org/10​.1186/s13063-016-1187-6. PMID: 1823905248; 45349. Exclusion Code: X6. [PMC free article: PMC4738764] [PubMed: 26841875]
225.
Ori R, Amos T, Bergman H, et al Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders. Cochrane Database Syst Rev. 2015 May 10(5):Cd007803. doi: 10.1002/14651858.CD007803.pub2. PMID: 25957940. Exclusion Code: X4. [PMC free article: PMC8939046] [PubMed: 25957940] [CrossRef]
226.
Otto MW, Hinton D, Korbly NB, et al Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone. Behav Res Ther. 2003 Nov;41(11):1271–6. PMID: 14527527. Exclusion Code: X4. [PubMed: 14527527]
227.
Pacella ML, Armelie A, Boarts J, et al The impact of prolonged exposure on PTSD symptoms and associated psychopathology in people living with HIV: a randomized test of concept. AIDS Behav. 2012 Jul;16(5):1327–40. doi: 10.1007/s10461-011-0076-y. PMID: 22012149. Exclusion Code: X3. [PMC free article: PMC4391814] [PubMed: 22012149] [CrossRef]
228.
Pae C-U, Lim H-K, Peindl K, et al The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Clin Psychopharmacol. 2008;23(1):1–8. doi: 10.1097/YIC.0b013e32825ea324. PMID: 2007-19245-001. Exclusion Code: X2. [PubMed: 18090502] [CrossRef]
229.
Peeler S, Chung MC, Stedmon J, et al A review assessing the current treatment strategies for postnatal psychological morbidity with a focus on post-traumatic stress disorder. Midwifery. 2013 Apr;29(4):377–88. doi: 10.1016/j.midw.2012.03.004. PMID: 23177594. Exclusion Code: X2. [PubMed: 23177594] [CrossRef]
230.
Petrakis IL, Poling J, Levinson C, et al Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biol Psychiatry. 2006 Oct 01;60(7):777–83. doi: 10.1016/j.biopsych.2006.03.074. PMID: 17008146. Exclusion Code: X4. [PubMed: 17008146] [CrossRef]
231.
Pigeon W, Heffner K, Crean H, et al Responding to the need for sleep among survivors of interpersonal violence: A randomized controlled trial of a cognitive-behavioral insomnia intervention followed by PTSD treatment. Contemp Clin Trials; 2015. p. 252–60. Exclusion Code: X6. [PMC free article: PMC4675039] [PubMed: 26343743]
232.
Pivac N, Kozaric-Kovacic D. Pharmacotherapy of treatment-resistant combat-related posttraumatic stress disorder with psychotic features. Croat Med J. 2016-09-15;47(3):440–51. PMID: 42434436; 28784. Exclusion Code: X2. [PMC free article: PMC2080433] [PubMed: 16758523]
233.
Pivac N, Kozaric-Kovacic D, Muck-Seler D. Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder. Psychopharmacology (Berl). 2004 Oct;175(4):451–6. doi: 10.1007/s00213-004-1849-z. PMID: 15064916. Exclusion Code: X2. [PubMed: 15064916] [CrossRef]
234.
Polak AR, Witteveen AB, Visser RS, et al Comparison of the effectiveness of trauma-focused cognitive behavioral therapy and paroxetine treatment in PTSD patients: design of a randomized controlled trial. BMC Psychiatry. 2012 Oct 09;12:166. doi: 10.1186/1471-244x-12-166. PMID: 23046608. Exclusion Code: X6. [PMC free article: PMC3539952] [PubMed: 23046608] [CrossRef]
235.
Powers MB, Medina JL, Burns S, et al Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data. Cogn Behav Ther. 2015;44(4):314–27. doi: 10.1080/16506073.2015.1012740. PMID: 25706090. Exclusion Code: X5. [PMC free article: PMC4464974] [PubMed: 25706090] [CrossRef]
236.
Pruiksma K, Davis J, Cranston C. A randomized controlled trial of exposure, relaxation, and rescripting therapy (ERRT) versus relaxation training (RT) for chronic nightmares in trauma-exposed persons: Preliminary findings. Sleep; 2012. p. A252–a3. Exclusion Code: X6.
237.
Pull CN, Pull CB. Current Status of Treatment for Posttraumatic Stress Disorder: Focus on Treatments Combining Pharmacotherapy and Cognitive-Behavioral Therapy. Int J Cogn Ther. 2014;7(2):149–61. doi: 10.1521/ijct.2014.7.2.149. PMID: 103952015. Language: English. Entry Date: 20140605. Revision Date: 20150710. Publication Type: Journal Article. Exclusion Code: X2. [CrossRef]
238.
Qi W, Gevonden M, Shalev A. Efficacy and tolerability of high-dose escitalopram in posttraumatic stress disorder. J Clin Psychopharmacol. 2017;37(1):89–93. doi: 10.1097/JCP.0000000000000626. PMID: 2017-03264-018. Exclusion Code: X2. [PMC free article: PMC6446897] [PubMed: 27977469] [CrossRef]
239.
Rahman A, Hamdani SU, Awan NR, et al Effect of a Multicomponent Behavioral Intervention in Adults Impaired by Psychological Distress in a Conflict-Affected Area of Pakistan: A Randomized Clinical Trial. JAMA. 2016 Dec 27;316(24):2609–17. doi: 10.1001/jama.2016.17165. PMID: 27837602. Exclusion Code: X3. [PubMed: 27837602] [CrossRef]
240.
Rees B, Travis F, Shapiro D, et al Reduction in posttraumatic stress symptoms in Congolese refugees practicing transcendental meditation. J Trauma Stress. 2013 Apr;26(2):295–8. doi: 10.1002/jts.21790. PMID: 23568415. Exclusion Code: X3. [PubMed: 23568415] [CrossRef]
241.
Regehr C, Alaggia R, Dennis J, et al Interventions to Reduce Distress in Adult Victims of Rape and Sexual Violence: A Systematic Review. Research on Social Work Practice. 2013;23(3):257–65. doi: 10.1177/1049731512474103. PMID: 104267571. Language: English. Entry Date: 20130419. Revision Date: 20150711. Publication Type: Journal Article. Exclusion Code: X2. [CrossRef]
242.
Resick PA, Suvak MK, Johnides BD, et al The impact of dissociation on PTSD treatment with cognitive processing therapy. Depress Anxiety. 2012 Aug;29(8):718–30. doi: 10.1002/da.21938. PMID: 22473922. Exclusion Code: X5. [PubMed: 22473922] [CrossRef]
243.
Resick PA, Suvak MK, Wells SY. The impact of childhood abuse among women with assault-related PTSD receiving short-term cognitive-behavioral therapy. J Trauma Stress. 2014 Oct;27(5):558–67. doi: 10.1002/jts.21951. PMID: 25322885. Exclusion Code: X6. [PubMed: 25322885] [CrossRef]
244.
Resick PA, Wachen JS, Dondanville KA, et al Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017-01-03;74(1):28–36. doi: 10.1001/jamapsychiatry.2016.2740 [45951]; Supplementary material accompanies the online version of this article.; Published online 23 November 2016. /10.1001/jamapsychiatry.2016.2729. PMID: 1853730963; 45949. Exclusion Code: X5. [PubMed: 27893032] [CrossRef]
245.
Rezaei Ardani A, Hosseini G, Fayyazi Bordbar MR, et al Effect of Rivastigmine Augmentation in Treatment of Male Patients With Combat-Related Chronic Posttraumatic Stress Disorder: A Randomized Controlled Trial. J Clin Psychopharmacol. 2017 Feb;37(1):54–60. doi: 10.1097/jcp.0000000000000624. PMID: 27930500. Exclusion Code: X4. [PubMed: 27930500] [CrossRef]
246.
Rimane E, Rosner R. Developmentally Adapted Cognitive Processing Therapy for Adolescents and Young Adults with PTSD Symptoms after Physical and Sexual Abuse - D-CPT. Http://www​.drks.de/DRKS00004787; 2013. Exclusion Code: X3. [PMC free article: PMC4055428] [PubMed: 24886027]
247.
Rizvi S, Vogt D, Resick P. Cognitive and affective predictors of treatment outcome in Cognitive Processing Therapy and Prolonged Exposure for posttraumatic stress disorder. Behav Res Ther; 2012. p. 737–43. Exclusion Code: X2. [PMC free article: PMC3467002] [PubMed: 19595295]
248.
Roberts NP, Roberts PA, Jones N, et al Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder. Cochrane Database Syst Rev. 2016 Apr 04;4:Cd010204. doi: 10.1002/14651858.CD010204.pub2. PMID: 27040448. Exclusion Code: X2. [PMC free article: PMC8782594] [PubMed: 27040448] [CrossRef]
249.
Roepke AM. Psychosocial interventions and posttraumatic growth: a meta-analysis. J Consult Clin Psychol. 2015 Feb;83(1):129–42. doi: 10.1037/a0036872. PMID: 24841865. Exclusion Code: X2. [PubMed: 24841865] [CrossRef]
250.
Ronconi JM, Shiner B, Watts BV. A Meta-Analysis of Depressive Symptom Outcomes in Randomized, Controlled Trials for PTSD. J Nerv Ment Dis. 2015 Jul;203(7):522–9. doi: 10.1097/nmd.0000000000000322. PMID: 26075838. Exclusion Code: X2. [PubMed: 26075838] [CrossRef]
251.
Rosen CS, Azevedo KJ, Tiet QQ, et al An RCT of effects of telephone care management on treatment adherence and clinical outcomes among veterans with PTSD. Psychiatr Serv. 2017-02-27;68(2):151–8. doi: http://dx​.doi.org/10​.1176/appi.ps.201600069. PMID: 1844925317; 45661. Exclusion Code: X4. [PubMed: 27745535]
252.
Rosen CS, Greenbaum MA, Schnurr PP, et al Do benzodiazepines reduce the effectiveness of exposure therapy for posttraumatic stress disorder? J Clin Psychiatry. 2013 Dec;74(12):1241–8. doi: 10.4088/JCP.13m08592. PMID: 24434093. Exclusion Code: X5. [PubMed: 24434093] [CrossRef]
253.
Rothbaum BO, Cahill SP, Foa EB, et al Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. J Trauma Stress. 2006 Oct;19(5):625–38. doi: 10.1002/jts.20170. PMID: 17075912. Exclusion Code: X4. [PubMed: 17075912] [CrossRef]
254.
Rothbaum BO, Kearns MC, Price M, et al Early intervention may prevent the development of posttraumatic stress disorder: a randomized pilot civilian study with modified prolonged exposure. Biol Psychiatry. 2012 Dec 01;72(11):957–63. doi: 10.1016/j.biopsych.2012.06.002. PMID: 22766415. Exclusion Code: X3. [PMC free article: PMC3467345] [PubMed: 22766415] [CrossRef]
255.
Rothbaum BO, Price M, Jovanovic T, et al A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry. 2014 Jun;171(6):640–8. doi: 10.1176/appi.ajp.2014.13121625. PMID: 24743802. Exclusion Code: X4. [PMC free article: PMC4115813] [PubMed: 24743802] [CrossRef]
256.
Roughead EE, Pratt NL, Kalisch Ellett LM, et al Posttraumatic Stress Disorder, Antipsychotic Use and Risk of Dementia in Veterans. J Am Geriatr Soc. 2017 Jul;65(7):1521–6. doi: 10.1111/jgs.14837. PMID: 28306156. Exclusion Code: X2. [PubMed: 28306156] [CrossRef]
257.
Roy MJ, Costanzo ME, Highland KB, et al An app a day keeps the doctor away: guided education and training via smartphones in subthreshold post traumatic stress disorder. Cyberpsychology, Behavior, and Social Networking. 2017 2017-09-05;20(8):470–8. doi: http://dx​.doi.org/10​.1089/cyber.2017.0221. PMID: 1935253987; 48649. Exclusion Code: X3. [PubMed: 28737954]
258.
Ruglass LM, Pedersen A, Cheref S, et al Racial differences in adherence and response to combined treatment for full and subthreshold post-traumatic stress disorder and alcohol use disorders: A secondary analysis. Journal of Ethnicity in Substance Abuse. 2016;15(4):434–48. doi: 10.1080/15332640.2015.1056927. PMID: 2016-60670-009. Exclusion Code: X5. [PMC free article: PMC5581661] [PubMed: 26422415] [CrossRef]
259.
Sack M, Zehl S, Otti A, et al A Comparison of Dual Attention, Eye Movements, and Exposure Only during Eye Movement Desensitization and Reprocessing for Posttraumatic Stress Disorder: Results from a Randomized Clinical Trial. Psychother Psychosom. 2016;85(6):357–65. doi: 10.1159/000447671. PMID: 27744424. Exclusion Code: X4. [PubMed: 27744424] [CrossRef]
260.
Saunders EC, McGovern MP, Lambert-Harris C, et al The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders. Am J Addict. 2015 Dec;24(8):722–31. doi: 10.1111/ajad.12292. PMID: 26388539. Exclusion Code: X5. [PMC free article: PMC4866634] [PubMed: 26388539] [CrossRef]
261.
Sautter FJ, Glynn SM, Becker-Cretu JB, et al Structured approach therapy for combat-related PTSD in returning U.S. veterans: complementary mediation by changes in emotion functioning. J Trauma Stress. 2016-09-15;29(4):384–7. doi: http://dx​.doi.org/10.1002/jts.22120. PMID: 1812432314; 45207. Exclusion Code: X6. [PubMed: 27472747]
262.
Schafer I, Chuey-Ferrer L, Hofmann A, et al Effectiveness of EMDR in patients with substance use disorder and comorbid PTSD: study protocol for a randomized controlled trial. BMC Psychiatry. 2017 Mar 16;17(1):95. doi: 10.1186/s12888-017-1255-9. PMID: 28302084. Exclusion Code: X1. [PMC free article: PMC5356401] [PubMed: 28302084] [CrossRef]
263.
Schneier FR, Neria Y, Pavlicova M, et al Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial. Am J Psychiatry. 2012 Jan;169(1):80–8. doi: 10.1176/appi.ajp.2011.11020321. PMID: 21908494. Exclusion Code: X4. [PMC free article: PMC3606709] [PubMed: 21908494] [CrossRef]
264.
Schnurr P, Lunney C. Differential effects of prolonged exposure on posttraumatic stress disorder symptoms in female veterans. J Consult Clin Psychol; 2015. p. 1154–60. Exclusion Code: X5. [PubMed: 26147562]
265.
Schnurr PP, Chard KM, Ruzek JI, et al Design of VA Cooperative Study #591: CERV-PTSD, comparative effectiveness research in veterans with PTSD. Contemp Clin Trials. 2015 Mar;41:75–84. doi: 10.1016/j.cct.2014.11.017. PMID: 25457792. Exclusion Code: X6. [PubMed: 25457792] [CrossRef]
266.
Schnurr PP, Friedman MJ, Oxman TE, et al RESPECT-PTSD: re-engineering systems for the primary care treatment of PTSD, a randomized controlled trial. J Gen Intern Med. 2016-09-15;28(1):32–40. doi: http://dx​.doi.org/10​.1007/s11606-012-2166-6. PMID: 1081869838; 39174. Exclusion Code: X4. [PMC free article: PMC3539037] [PubMed: 22865017]
267.
Schnurr PP, Lunney CA. Work-related outcomes among female veterans and service members after treatment of posttraumatic stress disorder. Psychiatr Serv. 2012 Nov;63(11):1072–9. doi: 10.1176/appi.ps.201100415. PMID: 22983600. Exclusion Code: X6. [PubMed: 22983600] [CrossRef]
268.
Schoenfeld FB, Marmar CR, Neylan TC. Current concepts in pharmacotherapy for posttraumatic stress disorder. Psychiatr Serv. 2016-09-15;55(5):519–31. doi: http://dx​.doi.org/10​.1176/appi.ps.55.5.519. PMID: 42424637; 26326. Exclusion Code: X2. [PubMed: 15128960]
269.
Schoorl M, Putman P, Van Der Does W. Attentional bias modification in posttraumatic stress disorder: a randomized controlled trial. Psychother Psychosom. 2013;82(2):99–105. doi: 10.1159/000341920. PMID: 23295710. Exclusion Code: X5. [PubMed: 23295710] [CrossRef]
270.
Schouten KA, de Niet GJ, Knipscheer JW, et al The effectiveness of art therapy in the treatment of traumatized adults: a systematic review on art therapy and trauma. Trauma Violence Abuse. 2015 Apr;16(2):220–8. doi: 10.1177/1524838014555032. PMID: 25403446. Exclusion Code: X2. [PubMed: 25403446] [CrossRef]
271.
Scott JC, Harb GC, Brownlow JAR, et al Verbal memory functioning moderates psychotherapy treatment response for PTSD-related nightmares. Behav Res Ther. 2017-03-01;91:24–32. doi: http://dx​.doi.org/10​.1016/j.brat.2017.01.004. PMID: 1872797524; 46881. Exclusion Code: X5. [PubMed: 28110112]
272.
Seppala EM, Nitschke JB, Tudorascu DL, et al Breathing-based meditation decreases posttraumatic stress disorder symptoms in U.S. military veterans: a randomized controlled longitudinal study. J Trauma Stress. 2014 Aug;27(4):397–405. doi: 10.1002/jts.21936. PMID: 25158633. Exclusion Code: X3. [PMC free article: PMC4309518] [PubMed: 25158633] [CrossRef]
273.
Shalev AY, Ankri YLE, Gilad M, et al Long-term outcome of early interventions to prevent posttraumatic stress disorder. J Clin Psychiatry. 2016-12-29;77(5):e580–e7. doi: 10.4088/JCP.15com10248 [45966]. http://dx​.doi.org/10.4088/JCP.15m09932. PMID: 1853730806; 45967. Exclusion Code: X2. [PubMed: 27135249] [CrossRef]
274.
Shepherd AJ. Treatment modalities of female Operation Iraqi Freedom/Operation Enduring Freedom Veterans with posttraumatic stress disorder: a systematic review of the literature [thesis]; 2012. Exclusion Code: X2.
275.
Short NA, Boffa JW, Norr AM, et al Randomized clinical trial investigating the effects of an anxiety sensitivity intervention on posttraumatic stress symptoms: a replication and extension. J Trauma Stress. 2017 2017-07-06;30(3):296–303. doi: http://dx​.doi.org/10.1002/jts.22194. PMID: 1916308471; 48281. Exclusion Code: X3. [PubMed: 28585746]
276.
Sin J, Spain D, Furuta M, et al Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness. Cochrane Database Syst Rev. 2017 Jan 24;1:Cd011464. doi: 10.1002/14651858.CD011464.pub2. PMID: 28116752. Exclusion Code: X2. [PMC free article: PMC6464771] [PubMed: 28116752] [CrossRef]
277.
Singh B, Hughes AJ, Mehta G, et al Efficacy of Prazosin in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis. Prim Care Companion CNS Disord. 2016 Jul 28;18(4)doi: 10.4088/PCC.16r01943. PMID: 27828694. Exclusion Code: X2. [PubMed: 27828694] [CrossRef]
278.
Sloan DM, Feinstein BA, Gallagher MW, et al Efficacy of group treatment for posttraumatic stress disorder symptoms: a meta-analysis. Psychological Trauma: Theory, Research, Practice, and Policy. 2016-09-15;5(2):176–83. doi: http://dx​.doi.org/10.1037/a0026291. PMID: 927827951; 37918. Exclusion Code: X2.
279.
Sloan DM, Marx B, Resick PA. Brief treatment for PTSD: a non-inferiority trial. Contemp Clin Trials. 2016-09-15;48:76–82. doi: http://dx​.doi.org/10​.1016/j.cct.2016.04.003. PMID: 1793561041; 44770. Exclusion Code: X6. [PMC free article: PMC4885749] [PubMed: 27080931]
280.
Sloan DM, Unger WS, Beck JG. Cognitive-behavioral group treatment for veterans diagnosed with PTSD: design of a hybrid efficacy-effectiveness clinical trial. Contemp Clin Trials. 2016-09-15;47:123–30. doi: http://dx​.doi.org/10​.1016/j.cct.2015.12.016. PMID: 1800697535; 44872. Exclusion Code: X6. [PMC free article: PMC4838993] [PubMed: 26718094]
281.
Smith ER, Porter KE, Messina MG, et al Prolonged Exposure for PTSD in a Veteran group: a pilot effectiveness study. J Anxiety Disord. 2015 Mar;30:23–7. doi: 10.1016/j.janxdis.2014.12.008. PMID: 25594370. Exclusion Code: X2. [PubMed: 25594370] [CrossRef]
282.
Spence J, Titov N, Johnston L, et al Internet-based trauma-focused cognitive behavioural therapy for PTSD with and without exposure components: a randomised controlled trial. J Affect Disord. 2014 Jun;162:73–80. doi: 10.1016/j.jad.2014.03.009. PMID: 24767009. Exclusion Code: X5. [PubMed: 24767009] [CrossRef]
283.
Spivak B, Strous RD, Shaked G, et al Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. J Clin Psychopharmacol. 2006 Apr;26(2):152–6. doi: 10.1097/01.jcp.0000203195.65710.f0. PMID: 16633143. Exclusion Code: X4. [PubMed: 16633143] [CrossRef]
284.
Steel C, Hardy A, Smith B, et al Cognitive-behaviour therapy for post-traumatic stress in schizophrenia. A randomized controlled trial. Psychol Med. 2016-11-01 doi: http://dx​.doi.org/10​.1017/s0033291716002117. PMID: 1834388910; 45487. Exclusion Code: X3. [PubMed: 27650432]
285.
Stein DJ, Rothbaum BO, Baldwin DS, et al A factor analysis of posttraumatic stress disorder symptoms using data pooled from two venlafaxine extended-release clinical trials. Brain and Behavior. 2016-09-15;3(6):738–46. doi: http://dx​.doi.org/10.1002/brb3.183. PMID: 1465177236; 41400. Exclusion Code: X2. [PMC free article: PMC3868178] [PubMed: 24363976]
286.
Steinert C, Bumke PJ, Hollekamp RL, et al Resource activation for treating post-traumatic stress disorder, co-morbid symptoms and impaired functioning: a randomized controlled trial in Cambodia. Psychol Med. 2017 2017-09-05;47(3):553–64. doi: http://dx​.doi.org/10​.1017/s0033291716002592. PMID: 1935254385; 48614. Exclusion Code: X3. [PubMed: 27804900]
287.
Stevens NR, Holmgreen L, Walt L, et al Web-based trauma intervention for veterans has physical health payoff in randomized trial. Psychological Trauma: Theory, Research, Practice, and Policy. 2016-12-01 doi: http://dx​.doi.org/10.1037/tra0000184. PMID: 1844925522; 45683. Exclusion Code: X3. [PubMed: 27657979]
288.
Stock EM, Copeland LA, Bush RL, et al Prevalence of QT prolongation among veterans with severe mental illness. Psychiatr Serv. 2013;64(10):942-. doi: 10.1176/appi.ps.201300212. PMID: 2013-35227-013. Exclusion Code: X5. [PubMed: 24081399] [CrossRef]
289.
Szabo C, Kelemen O, Keri S. Changes in FKBP5 expression and memory functions during cognitive-behavioral therapy in posttraumatic stress disorder: a preliminary study. Neurosci Lett. 2014 May 21;569:116–20. doi: 10.1016/j.neulet.2014.03.059. PMID: 24704382. Exclusion Code: X5. [PubMed: 24704382] [CrossRef]
290.
Talbot LS, Maguen S, Metzler TJ, et al Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial. Sleep. 2014 Feb 01;37(2):327–41. doi: 10.5665/sleep.3408. PMID: 24497661. Exclusion Code: X3. [PMC free article: PMC3900619] [PubMed: 24497661] [CrossRef]
291.
Tawa J, Murphy S. Psychopharmacological treatment for military posttraumatic stress disorder: An integrative review. Journal of the American Association of Nurse Practitioners. 2013;25(8):419–23. doi: 10.1111/1745-7599.12016. PMID: 104127345. Language: English. Entry Date: 20131218. Revision Date: 20150710. Publication Type: Journal Article. Exclusion Code: X2. [PubMed: 24170638] [CrossRef]
292.
Taylor FB, Lowe K, Thompson C, et al Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder. Biol Psychiatry. 2006 Apr 01;59(7):577–81. doi: 10.1016/j.biopsych.2005.09.023. PMID: 16460691. Exclusion Code: X6. [PubMed: 16460691] [CrossRef]
293.
Taylor FB, Martin P, Thompson C, et al Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study. Biol Psychiatry. 2008 Mar 15;63(6):629–32. doi: 10.1016/j.biopsych.2007.07.001. PMID: 17868655. Exclusion Code: X7. [PMC free article: PMC2350188] [PubMed: 17868655] [CrossRef]
294.
Thapa M, Petrakis I, Ralevski E. A Comparison of Sexual Side Effects of Antidepressants With and Without Naltrexone. Journal of Dual Diagnosis. 2017;13(3):230–5. doi: 10.1080/15504263.2017.1326650. PMID: 124481150. Language: English. Entry Date: 20170817. Revision Date: 20170829. Publication Type: Article. Journal Subset: Biomedical. Exclusion Code: X2. [PubMed: 28481169] [CrossRef]
295.
Thomaes K, Dorrepaal E, Balkom A, et al [Complex PTSD following early-childhood trauma: emotion-regulation training as addition to the PTSD guideline]. Tijdschrift voor psychiatrie; 2015. p. 171–82. Exclusion Code: X10. [PubMed: 25856740]
296.
Thomaes K, Dorrepaal E, Draijer N, et al Can pharmacological and psychological treatment change brain structure and function in PTSD? A systematic review. J Psychiatr Res. 2014 Mar;50:1–15. doi: 10.1016/j.jpsychires.2013.11.002. PMID: 24321592. Exclusion Code: X2. [PubMed: 24321592] [CrossRef]
297.
Thomaes K, Engelhard IM, Sijbrandij M, et al Degrading traumatic memories with eye movements: a pilot functional MRI study in PTSD. European Journal of Psychotraumatology. 2016-12-29;7 doi: http://dx​.doi.org/10.3402/ejpt.v7.31371. PMID: 1853730952; 45953. Exclusion Code: X6. [PMC free article: PMC5131454] [PubMed: 27906119]
298.
Thrasher S, Power M, Morant N, et al Social support moderates outcome in a randomized controlled trial of exposure therapy and (or) cognitive restructuring for chronic posttraumatic stress disorder. Can J Psychiatry; 2012. p. 187–90. Exclusion Code: X6. [PubMed: 20370970]
299.
Thunker J, Pietrowsky R. Effectiveness of a manualized imagery rehearsal therapy for patients suffering from nightmare disorders with and without a comorbidity of depression or PTSD. Behav Res Ther. 2012 Sep;50(9):558–64. doi: 10.1016/j.brat.2012.05.006. PMID: 22738908. Exclusion Code: X4. [PubMed: 22738908] [CrossRef]
300.
Tran K, Moulton K, Santesso N, et al Cognitive processing therapy for post-traumatic stress disorder: a systematic review and meta-analysis. CADTH Health Technologies Assessments. 2016-09-15(141):1–107. PMID: 1812432909; 45095. Exclusion Code: X2. [PubMed: 27227199]
301.
Tyler Boden M, Kimerling R, Kulkarni M, et al Coping among military veterans with PTSD in substance use disorder treatment. J Subst Abuse Treat. 2014 Aug;47(2):160–7. doi: 10.1016/j.jsat.2014.03.006. PMID: 24854218. Exclusion Code: X5. [PubMed: 24854218] [CrossRef]
302.
van Dam D, Ehring T, Vedel E, et al Trauma-focused treatment for posttraumatic stress disorder combined with CBT for severe substance use disorder: a randomized controlled trial. BMC Psychiatry. 2013 Jun 19;13:172. doi: 10.1186/1471-244x-13-172. PMID: 23782590. Exclusion Code: X4. [PMC free article: PMC3698199] [PubMed: 23782590] [CrossRef]
303.
van den Berg DP, de Bont PA, van der Vleugel BM, et al Trauma-Focused Treatment in PTSD Patients With Psychosis: Symptom Exacerbation, Adverse Events, and Revictimization. Schizophr Bull. 2016 May;42(3):693–702. doi: 10.1093/schbul/sbv172. PMID: 26609122. Exclusion Code: X2. [PMC free article: PMC4838096] [PubMed: 26609122] [CrossRef]
304.
van den Berg DPG, van der Vleugel BM, de Bont PAJM, et al Predicting trauma-focused treatment outcome in psychosis. Schizophr Res. 2017-03-24;176(2-3):239–44. doi: http://dx​.doi.org/10​.1016/j.schres.2016.07.016. PMID: 1844925468; 45858. Exclusion Code: X5. [PubMed: 27449253]
305.
Van Liempt S. Sleep disturbances and PTSD: a perpetual circle? European Journal of Psychotraumatology. 2016-09-15;3 doi: http://dx​.doi.org/10​.3402/ejpt.v3i0.19142. PMID: 1284056012; 39811. Exclusion Code: X2. [PMC free article: PMC3464455] [PubMed: 23050070]
306.
Van Minnen A, Van der Vleugel BM, Van den Berg DPG, et al Effectiveness of trauma-focused treatment for patients with psychosis with and without the dissociative subtype of post-traumatic stress disorder. Br J Psychiatry. 2017-03-30;209(4):347–8. doi: http://dx​.doi.org/10​.1192/bjp.bp.116.185579. PMID: 1882073155; 47289. Exclusion Code: X4. [PubMed: 27491533]
307.
van Schagen AM, Lancee J, de Groot IW, et al Imagery rehearsal therapy in addition to treatment as usual for patients with diverse psychiatric diagnoses suffering from nightmares: a randomized controlled trial. J Clin Psychiatry. 2015 Sep;76(9):e1105–13. doi: 10.4088/JCP.14m09216. PMID: 26455674. Exclusion Code: X3. [PubMed: 26455674] [CrossRef]
308.
Wachen JS, Jimenez S, Smith K, et al Long-term functional outcomes of women receiving cognitive processing therapy and prolonged exposure. Psychological Trauma: Theory, Research, Practice, and Policy. 2016-09-15;6(Suppl. 1):S58–S65. doi: http://dx​.doi.org/10.1037/a0035741. PMID: 1708514405; 44308. Exclusion Code: X2.
309.
Wade DJ, Varker T, Kartal D, et al Gender difference in outcomes following trauma-focused interventions for posttraumatic stress disorder: systematic review and meta-analysis. Psychological Trauma: Theory, Research, Practice, and Policy. 2016-12-01;8(3):356–64. doi: http://dx​.doi.org/10.1037/tra0000110. PMID: 1844925288; 44679. Exclusion Code: X2. [PubMed: 26854354]
310.
Wang HR, Woo YS, Bahk WM. Anticonvulsants to treat post-traumatic stress disorder. Human Psychopharmacology: Clinical and Experimental. 2014;29(5):427–33. doi: 10.1002/hup.2425. PMID: 2014-33570-001. Exclusion Code: X2. [PubMed: 25131430] [CrossRef]
311.
Wang Z, Wang J, Maercker A. Chinese My Trauma Recovery, a Web-based intervention for traumatized persons in two parallel samples: randomized controlled trial. J Med Internet Res. 2013 Sep 30;15(9):e213. doi: 10.2196/jmir.2690. PMID: 24080137. Exclusion Code: X3. [PMC free article: PMC3815433] [PubMed: 24080137] [CrossRef]
312.
Warner MD, Dorn MR, Peabody CA. Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares. Pharmacopsychiatry. 2001 Jul;34(4):128–31. doi: 10.1055/s-2001-15871. PMID: 11518472. Exclusion Code: X2. [PubMed: 11518472] [CrossRef]
313.
Watts BV, Schnurr PP, Mayo L, et al Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry. 2016-09-15;74(6):e541–e50. doi: 10.1136/eb-2013-101527 (February 2014) [42071].; Meta Analysis: 112 studies. http://dx​.doi.org/10.4088/JCP.12r08225. PMID: 1441265203; 41029. Exclusion Code: X2. [PubMed: 23842024] [CrossRef]
314.
Watts BV, Schnurr PP, Mayo L, et al Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. The Journal of Clinical Psychiatry. 2013;74(6):e551–e7. doi: 10.4088/JCP.12r08225. PMID: 2013-22956-016. Exclusion Code: X2. [PubMed: 23842024] [CrossRef]
315.
Weizman R, Laor N, Schujovitsky A, et al Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment. Psychiatry Res. 1996 Jul 31;63(2-3):143–50. PMID: 8878310. Exclusion Code: X2. [PubMed: 8878310]
316.
Wells A, Colbear JS. Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. J Clin Psychol. 2012 Apr;68(4):373–81. doi: 10.1002/jclp.20871. PMID: 24469928. Exclusion Code: X4. [PubMed: 24469928] [CrossRef]
317.
Wilen JS. A systematic review and network meta-analysis of psychosocial interventions for adults who are sexually abused as children [dissertation]; 2014. Exclusion Code: X2.
318.
Wisco BE, Baker AS, Sloan DM. Mechanisms of Change in Written Exposure Treatment of Posttraumatic Stress Disorder. Behav Ther. 2016 Jan;47(1):66–74. doi: 10.1016/j.beth.2015.09.005. PMID: 26763498. Exclusion Code: X5. [PMC free article: PMC4838994] [PubMed: 26763498] [CrossRef]
319.
Wisco BE, Sloan DM, Marx BP. Cognitive emotion regulation and written exposure therapy for posttraumatic stress disorder. Clinical Psychological Science. 2016-09-15;1(4):435–42. doi: http://dx​.doi.org/10​.1177/2167702613486630. PMID: 1676084315; 43618. Exclusion Code: X6. [PMC free article: PMC3904430] [PubMed: 24482755]
320.
Wolf EJ, Lunney CA, Schnurr PP. The influence of the dissociative subtype of posttraumatic stress disorder on treatment efficacy in female veterans and active duty service members. J Consult Clin Psychol. 2016 Jan;84(1):95–100. doi: 10.1037/ccp0000036. PMID: 26167946. Exclusion Code: X5. [PMC free article: PMC4830387] [PubMed: 26167946] [CrossRef]
321.
Wolff N, Huening J, Shi J, et al Implementation and effectiveness of integrated trauma and addiction treatment for incarcerated men. J Anxiety Disord. 2015 Mar;30:66–80. doi: 10.1016/j.janxdis.2014.10.009. PMID: 25617774. Exclusion Code: X2. [PMC free article: PMC4620997] [PubMed: 25617774] [CrossRef]
322.
Worthington JJ, 3rd, Kinrys G, Wygant LE, et al Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. Int Clin Psychopharmacol. 2005 Jan;20(1):9–11. PMID: 15602109. Exclusion Code: X3. [PubMed: 15602109]
323.
Wu S, Zhu X, Zhang Y, et al A new psychological intervention: “512 Psychological Intervention Model” used for military rescuers in Wenchuan Earthquake in China. Soc Psychiatry Psychiatr Epidemiol. 2012 Jul;47(7):1111–9. doi: 10.1007/s00127-011-0416-2. PMID: 21789502. Exclusion Code: X3. [PubMed: 21789502] [CrossRef]
324.
Yeterian JD, Berke DS, Litz BT. Psychosocial rehabilitation after war trauma with adaptive disclosure: design and rationale of a comparative efficacy trial. Contemp Clin Trials. 2017 2017-09-05;61:10–5. doi: http://dx​.doi.org/10​.1016/j.cct.2017.07.012. PMID: 1935254975; 48664. Exclusion Code: X2. [PubMed: 28713032]
325.
Yuen EK, Gros DF, Price M, et al Randomized Controlled Trial of Home-Based Telehealth Versus In-Person Prolonged Exposure for Combat-Related PTSD in Veterans: Preliminary Results. J Clin Psychol. 2015 Jun;71(6):500–12. doi: 10.1002/jclp.22168. PMID: 25809565. Exclusion Code: X5. [PubMed: 25809565] [CrossRef]
326.
Zalta AK, Gillihan SJ, Fisher AJ, et al Change in negative cognitions associated with PTSD predicts symptom reduction in prolonged exposure. J Consult Clin Psychol. 2014 Feb;82(1):171–5. doi: 10.1037/a0034735. PMID: 24188512. Exclusion Code: X6. [PMC free article: PMC3951922] [PubMed: 24188512] [CrossRef]
327.
Zandberg LJ, Rosenfield D, Alpert E, et al Predictors of dropout in concurrent treatment of posttraumatic stress disorder and alcohol dependence: Rate of improvement matters. Behav Res Ther. 2016 May;80:1–9. doi: 10.1016/j.brat.2016.02.005. PMID: 26972745. Exclusion Code: X4. [PMC free article: PMC4828304] [PubMed: 26972745] [CrossRef]
328.
Zandberg LJ, Rosenfield D, McLean CP, et al Concurrent treatment of posttraumatic stress disorder and alcohol dependence: Predictors and moderators of outcome. J Consult Clin Psychol. 2016 Jan;84(1):43–56. doi: 10.1037/ccp0000052. PMID: 26460570. Exclusion Code: X4. [PMC free article: PMC4695374] [PubMed: 26460570] [CrossRef]
329.
Zang Y, Hunt N, Cox T. A randomised controlled pilot study: the effectiveness of narrative exposure therapy with adult survivors of the Sichuan earthquake. BMC Psychiatry. 2013 Jan 31;13:41. doi: 10.1186/1471-244x-13-41. PMID: 23363689. Exclusion Code: X7. [PMC free article: PMC3570314] [PubMed: 23363689] [CrossRef]
330.
Zang Y, Hunt N, Cox T. Adapting narrative exposure therapy for Chinese earthquake survivors: a pilot randomised controlled feasibility study. BMC Psychiatry. 2014 Oct 03;14:262. doi: 10.1186/s12888-014-0262-3. PMID: 25927297. Exclusion Code: X5. [PMC free article: PMC4189751] [PubMed: 25927297] [CrossRef]
331.
Zang Y, Yu J, Chazin D, et al Changes in coping behavior in a randomized controlled trial of concurrent treatment for PTSD and alcohol dependence. Behav Res Ther. 2017-02-02;90:9–15. doi: http://dx​.doi.org/10​.1016/j.brat.2016.11.013. PMID: 1863569184; 46542. Exclusion Code: X6. [PubMed: 27930926]
332.
Zoellner LA, Telch M, Foa EB, et al Enhancing Extinction Learning in Posttraumatic Stress Disorder With Brief Daily Imaginal Exposure and Methylene Blue: A Randomized Controlled Trial. J Clin Psychiatry. 2017 Jul;78(7):e782–e9. doi: 10.4088/JCP.16m10936. PMID: 28686823. Exclusion Code: X4. [PubMed: 28686823] [CrossRef]
333.
Zohar J, Fostick L, Juven-Wetzler A, et al Secondary prevention of chronic PTSD by early and short-term administration of escitalopram: a prospective randomized, placebo-controlled, double-blind trial. J Clin Psychiatry. 2017 2017-09-05 doi: http://dx​.doi.org/10.4088/JCP.16m10730. PMID: 1935254992; 48583. Exclusion Code: X3. [PubMed: 28703951]

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (6.4M)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...